$EHC
Encompass Health Corp Stock $ehc

$ehc Overview Financials Valuation SEC Filings Company Website

2011 Q4 Form 8-K Financial Statement

#000078516112000055 Filed on September 06, 2012

Income Statement

Concept	2011 Q4	2010 Q4	2010 Q3
Revenue	$518.1M	$490.9M	$460.8M
YoY Change	5.54%	0.97%	-2.04%
Cost Of Revenue	$26.10M	$26.10M	$24.10M
YoY Change	0.0%	-9.38%	-12.68%
Gross Profit	$485.9M	$464.8M	$436.7M
YoY Change	4.54%	1.62%	-1.38%
Gross Profit Margin	93.78%	94.68%	94.77%
Selling, General & Admin	$298.2M	$282.7M	$276.9M
YoY Change	5.48%	-4.23%	-2.19%
% of Gross Profit	61.37%	60.82%	63.41%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$20.20M	$19.40M	$18.40M
YoY Change	4.12%	31.08%	3.37%
% of Gross Profit	4.16%	4.17%	4.21%
Operating Expenses	$390.1M	$374.2M	$360.7M
YoY Change	4.25%	-2.58%	-1.88%
Operating Profit	$95.80M	$90.60M	$76.00M
YoY Change	5.74%	23.6%	1.06%
Interest Expense	-$19.90M	-$31.90M	-$37.50M
YoY Change	-37.62%	0.0%	9.01%
% of Operating Profit	-20.77%	-35.21%	-49.34%
Other Income/Expense, Net	$1.200M	$1.500M	$700.0K
YoY Change	-20.0%	-25.0%	16.67%
Pretax Income	$82.70M	$47.10M	$38.30M
YoY Change	75.58%	47.65%	18.94%
Income Tax	$15.20M	-$741.5M	-$400.0K
% Of Pretax Income	18.38%	-1574.31%	-1.04%
Net Earnings	$50.00M	$779.2M	$31.80M
YoY Change	-93.58%	1918.65%	89.29%
Net Earnings / Revenue	9.65%	158.73%	6.9%
Basic Earnings Per Share	$0.45	$8.33	$0.27
Diluted Earnings Per Share	$0.46	$7.16	$0.27
COMMON SHARES
Basic Shares Outstanding			92.80M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2011 Q4	2010 Q4	2010 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$30.10M	$66.50M	$190.5M
YoY Change	-54.74%	-20.45%	52.4%
Cash & Equivalents	$30.10M	$48.30M	$190.5M
Short-Term Investments		$18.20M
Other Short-Term Assets	$138.1M	$133.0M	$108.6M
YoY Change	3.83%	8.39%	-24.11%
Inventory
Prepaid Expenses
Receivables	$222.8M	$206.7M	$215.2M
Other Receivables	$11.70M	$0.00	$0.00
Total Short-Term Assets	$491.6M	$406.2M	$514.3M
YoY Change	21.02%	-4.65%	6.19%
LONG-TERM ASSETS
Property, Plant & Equipment	$664.4M	$632.9M	$683.7M
YoY Change	4.98%	-4.8%	1.82%
Goodwill	$421.7M	$420.3M
YoY Change	0.33%	3.09%
Intangibles	$57.70M	$58.50M
YoY Change	-1.37%
Long-Term Investments	$27.10M	$28.10M	$31.60M
YoY Change	-3.56%	-4.1%	14.49%
Other Assets	$128.3M	$144.2M	$93.20M
YoY Change	-11.03%	45.66%	-15.27%
Total Long-Term Assets	$1.780B	$1.966B	$1.283B
YoY Change	-9.48%	56.58%	0.98%
TOTAL ASSETS
Total Short-Term Assets	$491.6M	$406.2M	$514.3M
Total Long-Term Assets	$1.780B	$1.966B	$1.283B
Total Assets	$2.271B	$2.372B	$1.797B
YoY Change	-4.25%	41.07%	2.42%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$45.40M	$44.60M	$49.30M
YoY Change	1.79%	-11.16%	-2.57%
Accrued Expenses	$107.5M	$98.50M	$324.5M
YoY Change	9.14%	16.29%	-12.25%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	-$18.90M	-$14.50M	$16.20M
YoY Change	30.34%	-167.44%	-26.03%
Total Short-Term Liabilities	$313.2M	$359.3M	$390.0M
YoY Change	-12.83%	-8.15%	-13.02%
LONG-TERM LIABILITIES
Long-Term Debt	$1.236B	$1.497B	$1.639B
YoY Change	-17.44%	-8.79%	-2.13%
Other Long-Term Liabilities	$30.40M	$28.30M	$162.7M
YoY Change	7.42%	-82.26%	-1.81%
Total Long-Term Liabilities	$1.266B	$1.525B	$1.802B
YoY Change	-16.98%	-15.3%	-2.1%
TOTAL LIABILITIES
Total Short-Term Liabilities	$313.2M	$359.3M	$390.0M
Total Long-Term Liabilities	$1.266B	$1.525B	$1.802B
Total Liabilities	$1.682B	$1.987B	$2.272B
YoY Change	-15.34%	-12.4%	-4.13%
SHAREHOLDERS EQUITY
Retained Earnings	-$2.610B	-$2.818B
YoY Change	-7.4%
Common Stock	$1.000M	$1.000M
YoY Change	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$148.8M	$141.8M
YoY Change	4.94%
Treasury Stock Shares	4.489M shares	4.180M shares
Shareholders Equity	$117.0M	-$85.20M	-$475.0M
YoY Change
Total Liabilities & Shareholders Equity	$2.271B	$2.372B	$1.797B
YoY Change	-4.25%	41.07%	2.42%

Cashflow Statement

Concept	2011 Q4	2010 Q4	2010 Q3
OPERATING ACTIVITIES
Net Income	$50.00M	$779.2M	$31.80M
YoY Change	-93.58%	1918.65%	89.29%
Depreciation, Depletion And Amortization	$20.20M	$19.40M	$18.40M
YoY Change	4.12%	31.08%	3.37%
Cash From Operating Activities	$129.4M	$66.90M	$91.00M
YoY Change	93.42%	52.05%	-31.53%
INVESTING ACTIVITIES
Capital Expenditures	-$47.20M	-$20.50M	-$19.70M
YoY Change	130.24%	19.88%	-0.51%
Acquisitions
YoY Change
Other Investing Activities	-$10.10M	-$14.60M	-$31.00M
YoY Change	-30.82%	-271.76%	15.67%
Cash From Investing Activities	-$57.30M	-$35.10M	-$50.70M
YoY Change	63.25%	308.14%	8.8%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-89.70M	-173.9M	-22.20M
YoY Change	-48.42%	142.54%	18.09%
NET CHANGE
Cash From Operating Activities	129.4M	66.90M	91.00M
Cash From Investing Activities	-57.30M	-35.10M	-50.70M
Cash From Financing Activities	-89.70M	-173.9M	-22.20M
Net Change In Cash	-17.60M	-142.1M	18.10M
YoY Change	-87.61%	291.46%	-73.19%
FREE CASH FLOW
Cash From Operating Activities	$129.4M	$66.90M	$91.00M
Capital Expenditures	-$47.20M	-$20.50M	-$19.70M
Free Cash Flow	$176.6M	$87.40M	$110.7M
YoY Change	102.06%	43.04%	-27.5%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2011Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	11700000	USD
CY2010Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	9700000	USD
CY2011Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	45400000	USD
CY2010Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	44600000	USD
CY2010Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	206700000	USD
CY2011Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	222800000	USD
CY2010Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	674300000	USD
CY2011Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	686900000	USD
CY2011Q4	us-gaap	Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-200000	USD
CY2010Q4	us-gaap	Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	500000	USD
CY2010Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	500000	USD
CY2011Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-200000	USD
CY2010Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2873500000	USD
CY2011Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2874700000	USD
CY2010	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	16400000	USD
CY2011	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	20300000	USD
CY2009	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	13400000	USD
CY2009	us-gaap	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	295700000	USD
CY2010	us-gaap	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	-599700000	USD
CY2011	us-gaap	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	136900000	USD
CY2011	us-gaap	Advertising Expense AdvertisingExpense	4600000	USD
CY2009	us-gaap	Advertising Expense AdvertisingExpense	4.6	USD
CY2010	us-gaap	Advertising Expense AdvertisingExpense	4.6	USD
CY2011Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	21400000	USD
CY2010Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	22700000	USD
CY2008Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	27600000	USD
CY2009Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	30100000	USD
CY2010	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	6300000	USD
CY2011	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	4200000	USD
CY2009	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	6600000	USD
CY2011	us-gaap	Amortization Of Leased Asset AmortizationOfLeasedAsset	11100000	USD
CY2009	us-gaap	Amortization Of Leased Asset AmortizationOfLeasedAsset	12300000	USD
CY2010	us-gaap	Amortization Of Leased Asset AmortizationOfLeasedAsset	12100000	USD
CY2011	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1800000	shares
CY2010	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2000000	shares
CY2010Q4	us-gaap	Assets Assets	2372100000	USD
CY2011Q4	us-gaap	Assets Assets	2271200000	USD
CY2010Q4	us-gaap	Assets Current AssetsCurrent	406200000	USD
CY2011Q4	us-gaap	Assets Current AssetsCurrent	391000000	USD
CY2011Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation AssetsOfDisposalGroupIncludingDiscontinuedOperation	12200000	USD
CY2010Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation AssetsOfDisposalGroupIncludingDiscontinuedOperation	77600000	USD
CY2011Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	4900000	USD
CY2010Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	19800000	USD
CY2010Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Noncurrent AssetsOfDisposalGroupIncludingDiscontinuedOperationNoncurrent	57800000	USD
CY2011Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Noncurrent AssetsOfDisposalGroupIncludingDiscontinuedOperationNoncurrent	7300000	USD
CY2011Q4	us-gaap	Available For Sale Equity Securities Amortized Cost Basis AvailableForSaleEquitySecuritiesAmortizedCostBasis	45200000	USD
CY2010Q4	us-gaap	Available For Sale Equity Securities Amortized Cost Basis AvailableForSaleEquitySecuritiesAmortizedCostBasis	36900000	USD
CY2011	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	0	USD
CY2010	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	400000	USD
CY2009	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	900000	USD
CY2009	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	-1300000	USD
CY2011	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	0	USD
CY2010	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	-100000	USD
CY2011Q4	us-gaap	Available For Sale Securities Gross Unrealized Losses1 AvailableForSaleSecuritiesGrossUnrealizedLosses1	700000	USD
CY2010Q4	us-gaap	Available For Sale Securities Gross Unrealized Losses1 AvailableForSaleSecuritiesGrossUnrealizedLosses1	100000	USD
CY2011Q4	us-gaap	Availableforsale Securities Gross Unrealized Gain AvailableforsaleSecuritiesGrossUnrealizedGain	700000	USD
CY2010Q4	us-gaap	Availableforsale Securities Gross Unrealized Gain AvailableforsaleSecuritiesGrossUnrealizedGain	700000	USD
CY2010Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	885600000	USD
CY2011Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	901400000	USD
CY2010Q4	us-gaap	Business Acquisition Cost Of Acquired Entity Purchase Price BusinessAcquisitionCostOfAcquiredEntityPurchasePrice	43200000	USD
CY2010Q4	us-gaap	Business Acquisition Purchase Price Allocation Assets Acquired BusinessAcquisitionPurchasePriceAllocationAssetsAcquired	43200000	USD
CY2010Q4	us-gaap	Business Acquisition Purchase Price Allocation Assets Acquired Liabilities Assumed Net BusinessAcquisitionPurchasePriceAllocationAssetsAcquiredLiabilitiesAssumedNet	42500000	USD
CY2010Q4	us-gaap	Business Acquisition Purchase Price Allocation Current Liabilities BusinessAcquisitionPurchasePriceAllocationCurrentLiabilities	700000	USD
CY2010Q4	us-gaap	Business Acquisition Purchase Price Allocation Goodwill Amount BusinessAcquisitionPurchasePriceAllocationGoodwillAmount	12600000	USD
CY2010Q4	us-gaap	Business Acquisition Purchase Price Allocation Property Plant And Equipment BusinessAcquisitionPurchasePriceAllocationPropertyPlantAndEquipment	17600000	USD
CY2010	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	902700000	USD
CY2009	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	100200000	USD
CY2011Q4	us-gaap	Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments	75900000	USD
CY2010Q4	us-gaap	Capital Leases Lessee Balance Sheet Assets By Major Class Accumulated Deprecation CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation	124900000	USD
CY2011Q4	us-gaap	Capital Leases Lessee Balance Sheet Assets By Major Class Accumulated Deprecation CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation	100300000	USD
CY2011	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	-8800000	USD
CY2010	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	-6500000	USD
CY2009	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	-8000000	USD
CY2010Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	48300000	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	30100000	USD
CY2009Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	80700000	USD
CY2010	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	1896100000	USD
CY2009	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	1817100000	USD
CY2010	us-gaap	Business Combination Pro Forma Information Earnings Or Loss Of Acquiree Since Acquisition Date Actual BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual	400000	USD
CY2010	us-gaap	Business Combination Pro Forma Information Revenue Of Acquiree Since Acquisition Date Actual BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual	10100000	USD
CY2011Q4	us-gaap	Capital Lease Obligations CapitalLeaseObligations	75900000	USD
CY2010Q4	us-gaap	Capital Lease Obligations CapitalLeaseObligations	89100000	USD
CY2011Q4	us-gaap	Capital Leased Assets Gross CapitalLeasedAssetsGross	161700000	USD
CY2010Q4	us-gaap	Capital Leased Assets Gross CapitalLeasedAssetsGross	197400000	USD
CY2010Q4	us-gaap	Capital Leases Balance Sheet Assets By Major Class Net CapitalLeasesBalanceSheetAssetsByMajorClassNet	72500000	USD
CY2011Q4	us-gaap	Capital Leases Balance Sheet Assets By Major Class Net CapitalLeasesBalanceSheetAssetsByMajorClassNet	61400000	USD
CY2011Q4	us-gaap	Capital Leases Future Minimum Payments Due CapitalLeasesFutureMinimumPaymentsDue	118900000	USD
CY2011Q4	us-gaap	Capital Leases Future Minimum Payments Due Current CapitalLeasesFutureMinimumPaymentsDueCurrent	16200000	USD
CY2011Q4	us-gaap	Capital Leases Future Minimum Payments Due In Five Years CapitalLeasesFutureMinimumPaymentsDueInFiveYears	8600000	USD
CY2011Q4	us-gaap	Capital Leases Future Minimum Payments Due In Four Years CapitalLeasesFutureMinimumPaymentsDueInFourYears	8900000	USD
CY2011Q4	us-gaap	Capital Leases Future Minimum Payments Due In Three Years CapitalLeasesFutureMinimumPaymentsDueInThreeYears	10500000	USD
CY2011Q4	us-gaap	Capital Leases Future Minimum Payments Due In Two Years CapitalLeasesFutureMinimumPaymentsDueInTwoYears	15000000	USD
CY2011Q4	us-gaap	Capital Leases Future Minimum Payments Due Thereafter CapitalLeasesFutureMinimumPaymentsDueThereafter	59700000	USD
CY2011Q4	us-gaap	Capital Leases Future Minimum Payments Interest Included In Payments CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments	43000000	USD
CY2008Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	31700000	USD
CY2009	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	48800000	USD
CY2010	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-32600000	USD
CY2011	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-18300000	USD
CY2010	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations	0	USD
CY2009	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations	1200000	USD
CY2011	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations	0	USD
CY2010	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	6900000	USD
CY2009	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	-1400000	USD
CY2011	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	9100000	USD
CY2010	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	13200000	USD
CY2009	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	5700000	USD
CY2009Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights	41.40
CY2004Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights	32.50
CY2011Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2010Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2010Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2011Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2010Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2011Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2010Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	97626393	shares
CY2011Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	99735959	shares
CY2010Q4	us-gaap	Common Stock Value CommonStockValue	1000000	USD
CY2011Q4	us-gaap	Common Stock Value CommonStockValue	1000000	USD
CY2011	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	208000000	USD
CY2010	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	899500000	USD
CY2009	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	98000000	USD
CY2010	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	40800000	USD
CY2009	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	34000000	USD
CY2011	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	45900000	USD
CY2011	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	253900000	USD
CY2009	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	132000000	USD
CY2010	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	940300000	USD
CY2010Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	14900000	USD
CY2011Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	10400000	USD
CY2011Q4	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	32.7869	shares
CY2011	us-gaap	Convertible Preferred Stock Terms Of Conversion ConvertiblePreferredStockTermsOfConversion	We may at any time cause the shares of preferred stock to be automatically converted into shares of our common stock at the conversion rate then in effect if the closing sale price of our common stock for 20 trading days within a period of 30 consecutive trading days ending on the trading day before the date we give the notice of forced conversion exceeds 150% of the conversion price of the preferred stock. If we are subject to a fundamental change, as defined in the certificate of designation of the preferred stock, each holder of shares of preferred stock has the right, subject to certain limitations, to require us to purchase with cash any or all of its shares of preferred stock at a purchase price equal to 100% of the accreted liquidation preference, plus any accrued and unpaid dividends to the date of purchase. In addition, if holders of the preferred stock elect to convert shares of preferred stock in connection with certain fundamental changes, we will in certain circumstances increase the conversion rate for such shares of preferred stock.
CY2011Q4	us-gaap	Cost Method Investments CostMethodInvestments	1900000	USD
CY2010Q4	us-gaap	Cost Method Investments CostMethodInvestments	2600000	USD
CY2010	us-gaap	Costs And Expenses CostsAndExpenses	1534500000	USD
CY2011	us-gaap	Costs And Expenses CostsAndExpenses	1619500000	USD
CY2009	us-gaap	Costs And Expenses CostsAndExpenses	1496800000	USD
CY2009	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	1800000	USD
CY2011	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	1400000	USD
CY2010	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	1300000	USD
CY2010	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	2900000	USD
CY2011	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	600000	USD
CY2009	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-7000000	USD
CY2010	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	1600000	USD
CY2009	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-8800000	USD
CY2011	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-800000	USD
CY2010Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	525000000	USD
CY2011Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	120000000	USD
CY2006Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	1000000000	USD
CY2009	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	3000000	USD
CY2010	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-682200000	USD
CY2011	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	48200000	USD
CY2010	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-743700000	USD
CY2011	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	36500000	USD
CY2009	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	4100000	USD
CY2011Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	7800000	USD
CY2010Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	8000000	USD
CY2009	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	1100000	USD
CY2011	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-11700000	USD
CY2010	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-61500000	USD
CY2010Q4	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	11800000	USD
CY2011Q4	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	4100000	USD
CY2010Q4	us-gaap	Deferred Tax Assets Equity Method Investments DeferredTaxAssetsEquityMethodInvestments	15600000	USD
CY2011Q4	us-gaap	Deferred Tax Assets Equity Method Investments DeferredTaxAssetsEquityMethodInvestments	10400000	USD
CY2010Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	820300000	USD
CY2011Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	705800000	USD
CY2011Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	634700000	USD
CY2010Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	707400000	USD
CY2010Q4	us-gaap	Deferred Tax Assets Liabilities Net Current DeferredTaxAssetsLiabilitiesNetCurrent	-28100000	USD
CY2011Q4	us-gaap	Deferred Tax Assets Liabilities Net Current DeferredTaxAssetsLiabilitiesNetCurrent	-26600000	USD
CY2011Q4	us-gaap	Deferred Tax Assets Liabilities Net Noncurrent DeferredTaxAssetsLiabilitiesNetNoncurrent	608100000	USD
CY2010Q4	us-gaap	Deferred Tax Assets Liabilities Net Noncurrent DeferredTaxAssetsLiabilitiesNetNoncurrent	679300000	USD
CY2011Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	655500000	USD
CY2010Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	707600000	USD
CY2010Q4	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	28100000	USD
CY2011Q4	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	26600000	USD
CY2010Q4	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	679300000	USD
CY2011Q4	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	608100000	USD
CY2011Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	540500000	USD
CY2010Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	628800000	USD
CY2010Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Alternative Minimum Tax DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax	13400000	USD
CY2011Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Alternative Minimum Tax DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax	13400000	USD
CY2011Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	22700000	USD
CY2010Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	19900000	USD
CY2011Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	12700000	USD
CY2010Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	12600000	USD
CY2010Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	21900000	USD
CY2011Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	16100000	USD
CY2011Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Self Insurance DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance	36100000	USD
CY2010Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Self Insurance DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance	37600000	USD
CY2011Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	50300000	USD
CY2010Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	112700000	USD
CY2010Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	200000	USD
CY2011Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	20800000	USD
CY2010Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	0	USD
CY2011Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	20500000	USD
CY2011Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	300000	USD
CY2010Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	200000	USD
CY2010	us-gaap	Depreciation Depreciation	48100000	USD
CY2011	us-gaap	Depreciation Depreciation	52500000	USD
CY2009	us-gaap	Depreciation Depreciation	43400000	USD
CY2010	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	73100000	USD
CY2011	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	78800000	USD
CY2009	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	67600000	USD
CY2010	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-13300000	USD
CY2009	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-19600000	USD
CY2011	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	0	USD
CY2010Q4	us-gaap	Disposal Group Including Discontinued Operation Accounts Notes And Loans Receivable Net DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet	18200000	USD
CY2010Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	6500000	USD
CY2009	us-gaap	Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax	13400000	USD
CY2011	us-gaap	Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax	65600000	USD
CY2010	us-gaap	Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax	0	USD
CY2009	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	4000000	USD
CY2010	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	14300000	USD
CY2011	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	21100000	USD
CY2011	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	37900000	USD
CY2010	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	4000000	USD
CY2009	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	-700000	USD
CY2011Q4	us-gaap	Disposal Group Including Discontinued Operation Accounts Notes And Loans Receivable Net DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet	4800000	USD
CY2010Q4	us-gaap	Disposal Group Including Discontinued Operation Accounts Payable DisposalGroupIncludingDiscontinuedOperationAccountsPayable	4500000	USD
CY2011Q4	us-gaap	Disposal Group Including Discontinued Operation Accounts Payable DisposalGroupIncludingDiscontinuedOperationAccountsPayable	1000000	USD
CY2011Q4	us-gaap	Disposal Group Including Discontinued Operation Goodwill DisposalGroupIncludingDiscontinuedOperationGoodwill	0	USD
CY2010Q4	us-gaap	Disposal Group Including Discontinued Operation Goodwill DisposalGroupIncludingDiscontinuedOperationGoodwill	11000000	USD
CY2010	us-gaap	Disposal Group Including Discontinued Operation Operating Expense DisposalGroupIncludingDiscontinuedOperationOperatingExpense	106400000	USD
CY2009	us-gaap	Disposal Group Including Discontinued Operation Operating Expense DisposalGroupIncludingDiscontinuedOperationOperatingExpense	133000000	USD
CY2011	us-gaap	Disposal Group Including Discontinued Operation Operating Expense DisposalGroupIncludingDiscontinuedOperationOperatingExpense	66300000	USD
CY2010Q4	us-gaap	Disposal Group Including Discontinued Operation Other Current Assets DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets	1600000	USD
CY2011Q4	us-gaap	Disposal Group Including Discontinued Operation Other Current Assets DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets	100000	USD
CY2011Q4	us-gaap	Disposal Group Including Discontinued Operation Other Current Liabilities DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities	5500000	USD
CY2010Q4	us-gaap	Disposal Group Including Discontinued Operation Other Current Liabilities DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities	7000000	USD
CY2011Q4	us-gaap	Disposal Group Including Discontinued Operation Other Noncurrent Assets DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets	400000	USD
CY2010Q4	us-gaap	Disposal Group Including Discontinued Operation Other Noncurrent Assets DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets	400000	USD
CY2010Q4	us-gaap	Disposal Group Including Discontinued Operation Property Plant And Equipment Net DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNet	46400000	USD
CY2011Q4	us-gaap	Disposal Group Including Discontinued Operation Property Plant And Equipment Net DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNet	6900000	USD
CY2010	us-gaap	Disposal Group Including Discontinued Operation Revenue DisposalGroupIncludingDiscontinuedOperationRevenue	123700000	USD
CY2011	us-gaap	Disposal Group Including Discontinued Operation Revenue DisposalGroupIncludingDiscontinuedOperationRevenue	95700000	USD
CY2009	us-gaap	Disposal Group Including Discontinued Operation Revenue DisposalGroupIncludingDiscontinuedOperationRevenue	144000000	USD
CY2011Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	6500000	USD
CY2011Q4	us-gaap	Equity Method Investment Underlying Equity In Net Assets EquityMethodInvestmentUnderlyingEquityInNetAssets	27100000	USD
CY2009	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	26000000	USD
CY2011Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.54
CY2010Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.37
CY2010	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	26000000	USD
CY2011	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	26000000	USD
CY2011Q4	us-gaap	Due From Related Parties Noncurrent DueFromRelatedPartiesNoncurrent	0	USD
CY2010Q4	us-gaap	Due From Related Parties Noncurrent DueFromRelatedPartiesNoncurrent	0	USD
CY2011Q4	us-gaap	Due To Related Parties Noncurrent DueToRelatedPartiesNoncurrent	0	USD
CY2010Q4	us-gaap	Due To Related Parties Noncurrent DueToRelatedPartiesNoncurrent	0	USD
CY2010	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	9.41
CY2011	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.96
CY2009	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.77
CY2010Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	8.33
CY2010Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.37
CY2010Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.44
CY2010Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.27
CY2011Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.54
CY2011Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.47
CY2011Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.79
CY2011Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.17
CY2009	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.77
CY2010	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	8.28
CY2011	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.96
CY2010Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	7.16
CY2010Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.27
CY2010Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.44
CY2011Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.46
CY2011Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.17
CY2011Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.73
CY2011	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.153
CY2010	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-3.901
CY2009	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.027
CY2010	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.350
CY2011	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.350
CY2009	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.350
CY2010	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-4.315
CY2009	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.223
CY2011	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.116
CY2009	us-gaap	Effective Income Tax Rate Reconciliation Minority Interest Income Expense EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense	-0.108
CY2011	us-gaap	Effective Income Tax Rate Reconciliation Minority Interest Income Expense EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense	-0.065
CY2010	us-gaap	Effective Income Tax Rate Reconciliation Minority Interest Income Expense EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense	-0.083
CY2011	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.013
CY2010	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.024
CY2011	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	13000000	USD
CY2009	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.008
CY2009	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.040
CY2011	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.030
CY2010	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.047
CY2010	us-gaap	Effective Income Tax Rate Reconciliation Tax Settlements EffectiveIncomeTaxRateReconciliationTaxSettlements	0.132
CY2009	us-gaap	Effective Income Tax Rate Reconciliation Tax Settlements EffectiveIncomeTaxRateReconciliationTaxSettlements	-0.066
CY2011	us-gaap	Effective Income Tax Rate Reconciliation Tax Settlements EffectiveIncomeTaxRateReconciliationTaxSettlements	-0.072
CY2010Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	77000000	USD
CY2011Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	85000000	USD
CY2011Q4	us-gaap	Equity Method Investment Aggregate Cost EquityMethodInvestmentAggregateCost	7200000	USD
CY2010Q4	us-gaap	Equity Method Investment Aggregate Cost EquityMethodInvestmentAggregateCost	7200000	USD
CY2009	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	8600000	USD
CY2010	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	8100000	USD
CY2011Q4	us-gaap	Equity Method Investment Summarized Financial Information Assets EquityMethodInvestmentSummarizedFinancialInformationAssets	90800000	USD
CY2010Q4	us-gaap	Equity Method Investment Summarized Financial Information Assets EquityMethodInvestmentSummarizedFinancialInformationAssets	91700000	USD
CY2010Q4	us-gaap	Equity Method Investment Summarized Financial Information Current Assets EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets	18000000	USD
CY2011Q4	us-gaap	Equity Method Investment Summarized Financial Information Current Assets EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets	17400000	USD
CY2010Q4	us-gaap	Equity Method Investment Summarized Financial Information Current Liabilities EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities	7500000	USD
CY2011Q4	us-gaap	Equity Method Investment Summarized Financial Information Current Liabilities EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities	8900000	USD
CY2009	us-gaap	Equity Method Investment Summarized Financial Information Income Loss From Continuing Operations Before Extraordinary Items EquityMethodInvestmentSummarizedFinancialInformationIncomeLossFromContinuingOperationsBeforeExtraordinaryItems	20500000	USD
CY2011	us-gaap	Equity Method Investment Summarized Financial Information Income Loss From Continuing Operations Before Extraordinary Items EquityMethodInvestmentSummarizedFinancialInformationIncomeLossFromContinuingOperationsBeforeExtraordinaryItems	26500000	USD
CY2010	us-gaap	Equity Method Investment Summarized Financial Information Income Loss From Continuing Operations Before Extraordinary Items EquityMethodInvestmentSummarizedFinancialInformationIncomeLossFromContinuingOperationsBeforeExtraordinaryItems	23000000	USD
CY2011Q4	us-gaap	Equity Method Investment Summarized Financial Information Liabilities And Equity EquityMethodInvestmentSummarizedFinancialInformationLiabilitiesAndEquity	90800000	USD
CY2010Q4	us-gaap	Equity Method Investment Summarized Financial Information Liabilities And Equity EquityMethodInvestmentSummarizedFinancialInformationLiabilitiesAndEquity	91700000	USD
CY2011Q4	us-gaap	Equity Method Investment Summarized Financial Information Minority Interest EquityMethodInvestmentSummarizedFinancialInformationMinorityInterest	47800000	USD
CY2010Q4	us-gaap	Equity Method Investment Summarized Financial Information Minority Interest EquityMethodInvestmentSummarizedFinancialInformationMinorityInterest	48900000	USD
CY2010	us-gaap	Equity Method Investment Summarized Financial Information Net Income Loss EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss	23000000	USD
CY2011	us-gaap	Equity Method Investment Summarized Financial Information Net Income Loss EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss	26500000	USD
CY2009	us-gaap	Equity Method Investment Summarized Financial Information Net Income Loss EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss	20500000	USD
CY2010Q4	us-gaap	Equity Method Investment Summarized Financial Information Noncurrent Assets EquityMethodInvestmentSummarizedFinancialInformationNoncurrentAssets	73700000	USD
CY2011Q4	us-gaap	Equity Method Investment Summarized Financial Information Noncurrent Assets EquityMethodInvestmentSummarizedFinancialInformationNoncurrentAssets	73400000	USD
CY2011Q4	us-gaap	Equity Method Investment Summarized Financial Information Noncurrent Liabilities EquityMethodInvestmentSummarizedFinancialInformationNoncurrentLiabilities	7000000	USD
CY2010Q4	us-gaap	Equity Method Investment Summarized Financial Information Noncurrent Liabilities EquityMethodInvestmentSummarizedFinancialInformationNoncurrentLiabilities	7200000	USD
CY2011	us-gaap	Equity Method Investment Summarized Financial Information Revenue EquityMethodInvestmentSummarizedFinancialInformationRevenue	87000000	USD
CY2010	us-gaap	Equity Method Investment Summarized Financial Information Revenue EquityMethodInvestmentSummarizedFinancialInformationRevenue	79800000	USD
CY2009	us-gaap	Equity Method Investment Summarized Financial Information Revenue EquityMethodInvestmentSummarizedFinancialInformationRevenue	73100000	USD
CY2010Q4	us-gaap	Equity Method Investment Underlying Equity In Net Assets EquityMethodInvestmentUnderlyingEquityInNetAssets	28100000	USD
CY2011Q4	us-gaap	Equity Method Investments EquityMethodInvestments	27100000	USD
CY2010Q4	us-gaap	Equity Method Investments EquityMethodInvestments	28100000	USD
CY2009	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	0	USD
CY2011	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	-700000	USD
CY2010	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	-19200000	USD
CY2011Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	125500000	USD
CY2010Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	109600000	USD
CY2010	us-gaap	Finite Lived Intangible Assets Amortization Expense FiniteLivedIntangibleAssetsAmortizationExpense	12900000	USD
CY2011	us-gaap	Finite Lived Intangible Assets Amortization Expense FiniteLivedIntangibleAssetsAmortizationExpense	15200000	USD
CY2009	us-gaap	Finite Lived Intangible Assets Amortization Expense FiniteLivedIntangibleAssetsAmortizationExpense	11900000	USD
CY2011Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	183200000	USD
CY2010Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	168100000	USD
CY2010Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	58500000	USD
CY2011Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	57700000	USD
CY2011Q4	us-gaap	Fixtures And Equipment Gross FixturesAndEquipmentGross	313000000	USD
CY2010Q4	us-gaap	Fixtures And Equipment Gross FixturesAndEquipmentGross	300200000	USD
CY2011	us-gaap	Future Amortization Expense Year Five FutureAmortizationExpenseYearFive	4900000	USD
CY2011	us-gaap	Future Amortization Expense Year Four FutureAmortizationExpenseYearFour	6100000	USD
CY2011	us-gaap	Future Amortization Expense Year One FutureAmortizationExpenseYearOne	12100000	USD
CY2011	us-gaap	Future Amortization Expense Year Three FutureAmortizationExpenseYearThree	7200000	USD
CY2011	us-gaap	Future Amortization Expense Year Two FutureAmortizationExpenseYearTwo	9400000	USD
CY2010	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-1400000	USD
CY2011	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-4300000	USD
CY2009	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-3400000	USD
CY2011	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-38800000	USD
CY2010	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-12300000	USD
CY2009	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-12500000	USD
CY2010Q4	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	11900000	USD
CY2010	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	106200000	USD
CY2009	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	104500000	USD
CY2011	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	110500000	USD
CY2010Q4	us-gaap	Goodwill Goodwill	420300000	USD
CY2011Q4	us-gaap	Goodwill Goodwill	421700000	USD
CY2009Q4	us-gaap	Goodwill Goodwill	407700000	USD
CY2008Q4	us-gaap	Goodwill Goodwill	406000000	USD
CY2011Q3	us-gaap	Net Income Loss NetIncomeLoss	57000000	USD
CY2010Q2	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	467300000	USD
CY2010Q1	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	458600000	USD
CY2010	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	-12600000	USD
CY2011	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	-1400000	USD
CY2009	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	0	USD
CY2009	us-gaap	Goodwill Other Changes GoodwillOtherChanges	2600000	USD
CY2009	us-gaap	Goodwill Written Off Related To Sale Of Business Unit GoodwillWrittenOffRelatedToSaleOfBusinessUnit	-900000	USD
CY2011Q4	us-gaap	Guarantee Obligations Maximum Exposure GuaranteeObligationsMaximumExposure	23900000	USD
CY2011	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	2026900000	USD
CY2010	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	1877600000	USD
CY2009	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	1784900000	USD
CY2010Q3	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	460800000	USD
CY2010Q4	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	490900000	USD
CY2011Q1	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	506000000	USD
CY2011Q3	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	497700000	USD
CY2011Q4	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	518100000	USD
CY2011Q2	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	505100000	USD
CY2011	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	158800000	USD
CY2010	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	889800000	USD
CY2009	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	77100000	USD
CY2009	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	33300000	USD
CY2010	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	40900000	USD
CY2011	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	47000000	USD
CY2010	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	189900000	USD
CY2009	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	107500000	USD
CY2011	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	242900000	USD
CY2010	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	930700000	USD
CY2011	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	205800000	USD
CY2009	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	110400000	USD
CY2010Q4	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	788600000	USD
CY2010Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	49200000	USD
CY2010Q3	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	38700000	USD
CY2010Q2	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	54200000	USD
CY2011Q4	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	67500000	USD
CY2011Q3	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	33600000	USD
CY2011Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	74000000	USD
CY2011Q2	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	30700000	USD
CY2011	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.42
CY2009	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.58
CY2010	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	9.31
CY2010Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.36
CY2010Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.24
CY2010Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.40
CY2010Q4	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	8.31
CY2011Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.17
CY2011Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.14
CY2011Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.60
CY2011Q4	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.52
CY2011	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.42
CY2009	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.58
CY2010	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	8.20
CY2010Q4	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	7.15
CY2010Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.36
CY2010Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.40
CY2010Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.24
CY2011Q4	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.50
CY2011Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.14
CY2011Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.17
CY2011Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.57
CY2011	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	48800000	USD
CY2009	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	18400000	USD
CY2010	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	9100000	USD
CY2010Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	3200000	USD
CY2010Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	1300000	USD
CY2010Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	3300000	USD
CY2010Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	1300000	USD
CY2011Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-5000000	USD
CY2011Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	34700000	USD
CY2011Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	1600000	USD
CY2011Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	17500000	USD
CY2010	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	9200000	USD
CY2009	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	17700000	USD
CY2011	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	49900000	USD
CY2009	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.19
CY2010	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.10
CY2011	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.54
CY2010Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.02
CY2010Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.04
CY2010Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.03
CY2010Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.01
CY2011Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.03
CY2011Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.37
CY2011	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	7000000	USD
CY2009	us-gaap	Income Taxes Paid IncomeTaxesPaid	-10500000	USD
CY2011Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.05
CY2011Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.19
CY2011	us-gaap	Income Tax Examination Interest Expense IncomeTaxExaminationInterestExpense	-4700000	USD
CY2009	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.19
CY2011	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.54
CY2010	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.08
CY2010Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.03
CY2010Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.04
CY2010Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.01
CY2010Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.01
CY2011Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.37
CY2011Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.16
CY2011Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.03
CY2011Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.04
CY2009	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	4600000	USD
CY2010	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	10100000	USD
CY2011	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	12000000	USD
CY2011Q4	us-gaap	Income Tax Examination Interest Accrued IncomeTaxExaminationInterestAccrued	-100000	USD
CY2010Q4	us-gaap	Income Tax Examination Interest Accrued IncomeTaxExaminationInterestAccrued	-300000	USD
CY2010	us-gaap	Income Tax Examination Interest Expense IncomeTaxExaminationInterestExpense	-1700000	USD
CY2009	us-gaap	Income Tax Examination Interest Expense IncomeTaxExaminationInterestExpense	-2300000	USD
CY2011Q4	us-gaap	Income Tax Examination Liability Refund Adjustment From Settlement With Taxing Authority IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority	18000000	USD
CY2011	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	37100000	USD
CY2010	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-740800000	USD
CY2009	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2900000	USD
CY2010Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1300000	USD
CY2010Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-400000	USD
CY2010Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-741500000	USD
CY2010Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2400000	USD
CY2011Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	18100000	USD
CY2011Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-7400000	USD
CY2011Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	15200000	USD
CY2011Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	11200000	USD
CY2009	us-gaap	Income Tax Expense Benefit Continuing Operations IncomeTaxExpenseBenefitContinuingOperations	-2900000	USD
CY2011	us-gaap	Income Tax Expense Benefit Continuing Operations IncomeTaxExpenseBenefitContinuingOperations	37100000	USD
CY2010	us-gaap	Income Tax Expense Benefit Continuing Operations IncomeTaxExpenseBenefitContinuingOperations	-740800000	USD
CY2011	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	28000000	USD
CY2011	us-gaap	Income Taxes Paid IncomeTaxesPaid	-9100000	USD
CY2010	us-gaap	Income Taxes Paid IncomeTaxesPaid	-10000000	USD
CY2009	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	4600000	USD
CY2011	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	800000	USD
CY2010	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-800000	USD
CY2011	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	37100000	USD
CY2010	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	21500000	USD
CY2009	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	16500000	USD
CY2011	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	3700000	USD
CY2010	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	100000	USD
CY2009	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	-10900000	USD
CY2009	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-45900000	USD
CY2011	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-2500000	USD
CY2010	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-7500000	USD
CY2010	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	14700000	USD
CY2009	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-800000	USD
CY2011	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	1000000	USD
CY2011	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	4100000	USD
CY2010	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	8100000	USD
CY2009	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-100000	USD
CY2011	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	12500000	USD
CY2010	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	7900000	USD
CY2009	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-3800000	USD
CY2009	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	11700000	USD
CY2010	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	-31300000	USD
CY2011	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	-1200000	USD
CY2011	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	13100000	shares
CY2010	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	13100000	shares
CY2009	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	13100000	shares
CY2011Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	57700000	USD
CY2010Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	58500000	USD
CY2011	us-gaap	Interest And Debt Expense InterestAndDebtExpense	119400000	USD
CY2009	us-gaap	Interest And Debt Expense InterestAndDebtExpense	125700000	USD
CY2010	us-gaap	Interest And Debt Expense InterestAndDebtExpense	125600000	USD
CY2009	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	0	USD
CY2010	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	400000	USD
CY2011	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	500000	USD
CY2010	us-gaap	Interest Paid InterestPaid	-106100000	USD
CY2011	us-gaap	Interest Paid InterestPaid	-115400000	USD
CY2009	us-gaap	Interest Paid InterestPaid	-121300000	USD
CY2011Q4	us-gaap	Interest Payable Current InterestPayableCurrent	22500000	USD
CY2010Q4	us-gaap	Interest Payable Current InterestPayableCurrent	21500000	USD
CY2010Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	30700000	USD
CY2011Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	29000000	USD
CY2011Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2271200000	USD
CY2010Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2372100000	USD
CY2011Q4	us-gaap	Liabilities Current LiabilitiesCurrent	313200000	USD
CY2011Q4	us-gaap	Land Land	66900000	USD
CY2010Q4	us-gaap	Land Land	63400000	USD
CY2010Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	43100000	USD
CY2011Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	59600000	USD
CY2010Q4	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	48700000	USD
CY2010Q4	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	45600000	USD
CY2011Q4	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	44600000	USD
CY2010Q4	us-gaap	Liabilities Liabilities	1986900000	USD
CY2011Q4	us-gaap	Liabilities Liabilities	1682200000	USD
CY2010Q4	us-gaap	Liabilities Current LiabilitiesCurrent	359300000	USD
CY2010Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation	12700000	USD
CY2011Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation	7200000	USD
CY2010Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	11500000	USD
CY2011Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	6500000	USD
CY2011Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Noncurrent LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent	700000	USD
CY2010Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Noncurrent LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent	1200000	USD
CY2010Q4	us-gaap	Line Of Credit LineOfCredit	78000000	USD
CY2011Q4	us-gaap	Line Of Credit LineOfCredit	110000000	USD
CY2010Q4	us-gaap	Line Of Credit Facility Interest Rate At Period End LineOfCreditFacilityInterestRateAtPeriodEnd	0.038
CY2011Q4	us-gaap	Line Of Credit Facility Interest Rate At Period End LineOfCreditFacilityInterestRateAtPeriodEnd	0.026
CY2011	us-gaap	Litigation Settlement Gross LitigationSettlementGross	0	USD
CY2010	us-gaap	Litigation Settlement Gross LitigationSettlementGross	0	USD
CY2009	us-gaap	Litigation Settlement Gross LitigationSettlementGross	-100000000	USD
CY2011Q4	us-gaap	Long Term Debt LongTermDebt	1254700000	USD
CY2010Q4	us-gaap	Long Term Debt LongTermDebt	1511300000	USD
CY2010Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	14500000	USD
CY2011Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	18900000	USD
CY2011Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	-18900000	USD
CY2010Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	-14500000	USD
CY2011Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1235800000	USD
CY2010Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1496800000	USD
CY2009	us-gaap	Management Fees Revenue ManagementFeesRevenue	0	USD
CY2011	us-gaap	Management Fees Revenue ManagementFeesRevenue	0	USD
CY2010	us-gaap	Management Fees Revenue ManagementFeesRevenue	0	USD
CY2011Q4	us-gaap	Marketable Securities Restricted MarketableSecuritiesRestricted	45200000	USD
CY2010Q4	us-gaap	Marketable Securities Restricted MarketableSecuritiesRestricted	37500000	USD
CY2010Q4	us-gaap	Marketable Securities Restricted Current MarketableSecuritiesRestrictedCurrent	18200000	USD
CY2011Q4	us-gaap	Marketable Securities Restricted Current MarketableSecuritiesRestrictedCurrent	15000000	USD
CY2010Q4	us-gaap	Marketable Securities Restricted Noncurrent MarketableSecuritiesRestrictedNoncurrent	19300000	USD
CY2011Q4	us-gaap	Marketable Securities Restricted Noncurrent MarketableSecuritiesRestrictedNoncurrent	30200000	USD
CY2011Q4	us-gaap	Minimum Lease Payments Sale Leaseback Transactions Thereafter MinimumLeasePaymentsSaleLeasebackTransactionsThereafter	19400000	USD
CY2011Q4	us-gaap	Minimum Lease Payments Sale Leaseback Transactions Within Five Years MinimumLeasePaymentsSaleLeasebackTransactionsWithinFiveYears	2700000	USD
CY2011Q4	us-gaap	Minimum Lease Payments Sale Leaseback Transactions Within Four Years MinimumLeasePaymentsSaleLeasebackTransactionsWithinFourYears	2700000	USD
CY2011Q4	us-gaap	Minimum Lease Payments Sale Leaseback Transactions Within One Year MinimumLeasePaymentsSaleLeasebackTransactionsWithinOneYear	2700000	USD
CY2011Q4	us-gaap	Minimum Lease Payments Sale Leaseback Transactions Within Three Years MinimumLeasePaymentsSaleLeasebackTransactionsWithinThreeYears	2700000	USD
CY2011Q4	us-gaap	Minimum Lease Payments Sale Leaseback Transactions Within Two Years MinimumLeasePaymentsSaleLeasebackTransactionsWithinTwoYears	2700000	USD
CY2011Q4	us-gaap	Minority Interest MinorityInterest	84600000	USD
CY2010Q4	us-gaap	Minority Interest MinorityInterest	83000000	USD
CY2010	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	36600000	USD
CY2011	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	40500000	USD
CY2009	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	34600000	USD
CY2009	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-224300000	USD
CY2011	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-336400000	USD
CY2010	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-237700000	USD
CY2010	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-125900000	USD
CY2009	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-133000000	USD
CY2011	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-24600000	USD
CY2011	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	342700000	USD
CY2010	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	331000000	USD
CY2009	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	406100000	USD
CY2009	us-gaap	Net Income Loss NetIncomeLoss	94800000	USD
CY2011	us-gaap	Net Income Loss NetIncomeLoss	208700000	USD
CY2010	us-gaap	Net Income Loss NetIncomeLoss	899000000	USD
CY2010Q3	us-gaap	Net Income Loss NetIncomeLoss	31800000	USD
CY2010Q1	us-gaap	Net Income Loss NetIncomeLoss	40700000	USD
CY2010Q4	us-gaap	Net Income Loss NetIncomeLoss	779200000	USD
CY2010Q2	us-gaap	Net Income Loss NetIncomeLoss	47300000	USD
CY2011Q4	us-gaap	Net Income Loss NetIncomeLoss	50000000	USD
CY2011Q2	us-gaap	Net Income Loss NetIncomeLoss	21900000	USD
CY2011Q1	us-gaap	Net Income Loss NetIncomeLoss	79800000	USD
CY2009	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	34000000	USD
CY2011Q4	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	12500000	USD
CY2011Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	11700000	USD
CY2011	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	45900000	USD
CY2010	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	40800000	USD
CY2010Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	10200000	USD
CY2010Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	10100000	USD
CY2010Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	9800000	USD
CY2010Q4	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	10700000	USD
CY2011Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	11300000	USD
CY2011Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	10400000	USD
CY2010	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	873000000	USD
CY2009	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	68800000	USD
CY2011	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	182700000	USD
CY2010	us-gaap	Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1	-11400000	USD
CY2011	us-gaap	Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1	-2800000	USD
CY2009	us-gaap	Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1	0	USD
CY2011	us-gaap	Noncash Or Part Noncash Acquisition Other Liabilities Assumed1 NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1	0	USD
CY2009	us-gaap	Noncash Or Part Noncash Acquisition Other Liabilities Assumed1 NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1	0	USD
CY2010	us-gaap	Noncash Or Part Noncash Acquisition Other Liabilities Assumed1 NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1	-700000	USD
CY2009	us-gaap	Notes Issued1 NotesIssued1	0	USD
CY2011	us-gaap	Notes Issued1 NotesIssued1	0	USD
CY2010	us-gaap	Notes Issued1 NotesIssued1	-8400000	USD
CY2011Q4	us-gaap	Number Of States In Which Entity Operates NumberOfStatesInWhichEntityOperates	27
CY2011Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	269400000	USD
CY2011Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	41100000	USD
CY2011Q4	us-gaap	Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals	14900000	USD
CY2011Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	22600000	USD
CY2011Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	28100000	USD
CY2011Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	32500000	USD
CY2011Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	38400000	USD
CY2011Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	106700000	USD
CY2009	us-gaap	Operating Leases Income Statement Sublease Revenue OperatingLeasesIncomeStatementSubleaseRevenue	4900000	USD
CY2011	us-gaap	Operating Leases Income Statement Sublease Revenue OperatingLeasesIncomeStatementSubleaseRevenue	4700000	USD
CY2010	us-gaap	Operating Leases Income Statement Sublease Revenue OperatingLeasesIncomeStatementSubleaseRevenue	4400000	USD
CY2010	us-gaap	Operating Leases Rent Expense Contingent Rentals OperatingLeasesRentExpenseContingentRentals	18800000	USD
CY2009	us-gaap	Operating Leases Rent Expense Contingent Rentals OperatingLeasesRentExpenseContingentRentals	24800000	USD
CY2011	us-gaap	Operating Leases Rent Expense Contingent Rentals OperatingLeasesRentExpenseContingentRentals	24200000	USD
CY2009	us-gaap	Operating Leases Rent Expense Minimum Rentals OperatingLeasesRentExpenseMinimumRentals	33200000	USD
CY2011	us-gaap	Operating Leases Rent Expense Minimum Rentals OperatingLeasesRentExpenseMinimumRentals	38500000	USD
CY2010	us-gaap	Operating Leases Rent Expense Minimum Rentals OperatingLeasesRentExpenseMinimumRentals	39900000	USD
CY2011	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	66900000	USD
CY2010	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	63400000	USD
CY2009	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	62200000	USD
CY2011Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	1300000000	USD
CY2011Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	99300000	USD
CY2010Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	144200000	USD
CY2011Q2	us-gaap	Profit Loss ProfitLoss	32300000	USD
CY2009	us-gaap	Other Comprehensive Income Loss Net Of Tax Period Increase Decrease OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease	3200000	USD
CY2011	us-gaap	Other Comprehensive Income Loss Net Of Tax Period Increase Decrease OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease	-700000	USD
CY2011	us-gaap	Other Comprehensive Income Loss Before Tax Period Increase Decrease OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecrease	-700000	USD
CY2010	us-gaap	Other Comprehensive Income Loss Before Tax Period Increase Decrease OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecrease	-900000	USD
CY2009	us-gaap	Other Comprehensive Income Loss Before Tax Period Increase Decrease OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecrease	3200000	USD
CY2009	us-gaap	Other Comprehensive Income Reclassification Adjustment For Sale Of Securities Included In Net Income Before Tax OtherComprehensiveIncomeReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeBeforeTax	1600000	USD
CY2011	us-gaap	Other Comprehensive Income Reclassification Adjustment For Sale Of Securities Included In Net Income Before Tax OtherComprehensiveIncomeReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeBeforeTax	0	USD
CY2010	us-gaap	Other Comprehensive Income Reclassification Adjustment For Sale Of Securities Included In Net Income Before Tax OtherComprehensiveIncomeReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeBeforeTax	-1300000	USD
CY2010	us-gaap	Other Comprehensive Income Reclassification Adjustment On Derivatives Included In Net Income Before Tax OtherComprehensiveIncomeReclassificationAdjustmentOnDerivativesIncludedInNetIncomeBeforeTax	4600000	USD
CY2010	us-gaap	Other Comprehensive Income Loss Net Of Tax Period Increase Decrease OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease	500000	USD
CY2011	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	0	USD
CY2010	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	1400000	USD
CY2009	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	0	USD
CY2011	us-gaap	Other Comprehensive Income Reclassification Adjustment On Derivatives Included In Net Income Before Tax OtherComprehensiveIncomeReclassificationAdjustmentOnDerivativesIncludedInNetIncomeBeforeTax	0	USD
CY2009	us-gaap	Other Comprehensive Income Reclassification Adjustment On Derivatives Included In Net Income Before Tax OtherComprehensiveIncomeReclassificationAdjustmentOnDerivativesIncludedInNetIncomeBeforeTax	0	USD
CY2010	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax	-4700000	USD
CY2011	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax	0	USD
CY2009	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax	300000	USD
CY2011	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-700000	USD
CY2009	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	1300000	USD
CY2010	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	500000	USD
CY2010	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	269500000	USD
CY2011	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	284000000	USD
CY2009	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	246700000	USD
CY2011Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	134100000	USD
CY2010Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	153400000	USD
CY2011Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	30400000	USD
CY2010Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	28300000	USD
CY2009	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-500000	USD
CY2011	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	600000	USD
CY2010	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	1800000	USD
CY2010	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	4300000	USD
CY2009	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	3300000	USD
CY2011	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2700000	USD
CY2009	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	800000	USD
CY2009	us-gaap	Payments For Proceeds From Derivative Instrument Investing Activities PaymentsForProceedsFromDerivativeInstrumentInvestingActivities	42200000	USD
CY2010	us-gaap	Payments For Proceeds From Derivative Instrument Investing Activities PaymentsForProceedsFromDerivativeInstrumentInvestingActivities	44700000	USD
CY2011	us-gaap	Payments For Proceeds From Derivative Instrument Investing Activities PaymentsForProceedsFromDerivativeInstrumentInvestingActivities	10900000	USD
CY2010	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	400000	USD
CY2009	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	1200000	USD
CY2011	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	900000	USD
CY2009	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	32700000	USD
CY2011	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	44200000	USD
CY2010	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	34400000	USD
CY2010	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	26000000	USD
CY2009	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	26000000	USD
CY2011	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	26000000	USD
CY2011	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	4900000	USD
CY2009	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2010	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	34100000	USD
CY2011	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	100300000	USD
CY2009	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	63300000	USD
CY2010	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	62800000	USD
CY2011	us-gaap	Payments To Acquire Restricted Investments PaymentsToAcquireRestrictedInvestments	8400000	USD
CY2009	us-gaap	Payments To Acquire Restricted Investments PaymentsToAcquireRestrictedInvestments	3800000	USD
CY2010	us-gaap	Payments To Acquire Restricted Investments PaymentsToAcquireRestrictedInvestments	26000000	USD
CY2011	us-gaap	Preferred Stock Dividend Rate Percentage PreferredStockDividendRatePercentage	0.0650
CY2010Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	68400000	USD
CY2011Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	61200000	USD
CY2010	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	0	USD
CY2011	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	107900000	USD
CY2009	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	0	USD
CY2011	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	9600000	USD
CY2010	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	15700000	USD
CY2009	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	63700000	USD
CY2009	us-gaap	Proceeds From Issuance Of Other Long Term Debt ProceedsFromIssuanceOfOtherLongTermDebt	15500000	USD
CY2010	us-gaap	Proceeds From Issuance Of Other Long Term Debt ProceedsFromIssuanceOfOtherLongTermDebt	0	USD
CY2011	us-gaap	Proceeds From Issuance Of Other Long Term Debt ProceedsFromIssuanceOfOtherLongTermDebt	0	USD
CY2010	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	0	USD
CY2009	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	0	USD
CY2011	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	100000000	USD
CY2010	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	525000000	USD
CY2009	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	290000000	USD
CY2011	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	120000000	USD
CY2011	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	338000000	USD
CY2010	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	100000000	USD
CY2009	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	10000000	USD
CY2011	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	4300000	USD
CY2009	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	900000	USD
CY2010	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	5200000	USD
CY2010	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	0	USD
CY2011	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	0	USD
CY2009	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	0	USD
CY2011	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	0	USD
CY2010	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	5200000	USD
CY2009	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	5000000	USD
CY2008Q1	us-gaap	Proceeds From Sale Of Buildings ProceedsFromSaleOfBuildings	43500000	USD
CY2011	us-gaap	Proceeds From Sale Of Restricted Investments ProceedsFromSaleOfRestrictedInvestments	1200000	USD
CY2009	us-gaap	Proceeds From Sale Of Restricted Investments ProceedsFromSaleOfRestrictedInvestments	5000000	USD
CY2010	us-gaap	Proceeds From Sale Of Restricted Investments ProceedsFromSaleOfRestrictedInvestments	10400000	USD
CY2009	us-gaap	Profit Loss ProfitLoss	128800000	USD
CY2010	us-gaap	Profit Loss ProfitLoss	939800000	USD
CY2010Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1292300000	USD
CY2011Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1340900000	USD
CY2010Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	632900000	USD
CY2011Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	664400000	USD
CY2011	us-gaap	Profit Loss ProfitLoss	254600000	USD
CY2010Q2	us-gaap	Profit Loss ProfitLoss	57500000	USD
CY2010Q3	us-gaap	Profit Loss ProfitLoss	41900000	USD
CY2010Q4	us-gaap	Profit Loss ProfitLoss	789900000	USD
CY2010Q1	us-gaap	Profit Loss ProfitLoss	50500000	USD
CY2011Q1	us-gaap	Profit Loss ProfitLoss	91500000	USD
CY2011Q3	us-gaap	Profit Loss ProfitLoss	68300000	USD
CY2011Q4	us-gaap	Profit Loss ProfitLoss	62500000	USD
CY2010	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	16400000	USD
CY2011	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	21000000	USD
CY2009	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	30700000	USD
CY2011Q4	us-gaap	Reinsurance Receivables Paid Losses Recoverable ReinsuranceReceivablesPaidLossesRecoverable	35300000	USD
CY2010Q4	us-gaap	Reinsurance Receivables Paid Losses Recoverable ReinsuranceReceivablesPaidLossesRecoverable	34100000	USD
CY2009	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	13400000	USD
CY2010	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	14900000	USD
CY2011	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	13200000	USD
CY2009	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	409200000	USD
CY2011	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	504900000	USD
CY2010	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	751300000	USD
CY2010	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	22000000	USD
CY2011	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	306000000	USD
CY2009	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	50000000	USD
CY2010Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	36500000	USD
CY2011Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	35300000	USD
CY2011Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2609700000	USD
CY2010Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2818400000	USD
CY2011	us-gaap	Revenue Recognition Accounting Policy Gross And Net Revenue Disclosure RevenueRecognitionAccountingPolicyGrossAndNetRevenueDisclosure	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Net Operating Revenues—</font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the year ended December 31, 2012, 2011, and 2010, we derived consolidated </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Net operating revenues</font><font style="font-family:inherit;font-size:10pt;"> from the following payor sources:</font></div><div style="line-height:120%;padding-bottom:13px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td width="62%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">For the Year Ended December 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2011</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2010</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2009</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Medicare</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">72.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">70.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">67.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Medicaid</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Workers' compensation</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Managed care and other discount plans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other third-party payors</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Patients</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other income</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We recognize net patient service revenues in the reporting period in which we perform the service based on our current billing rates (i.e., gross charges), less actual adjustments and estimated discounts for contractual allowances (principally for patients covered by Medicare, Medicaid, and managed care and other health plans). We record gross service charges in our accounting records on an accrual basis using our established rates for the type of service provided to the patient. We recognize an estimated contractual allowance to reduce gross patient charges to the amount we estimate we will actually realize for the service rendered based upon previously agreed to rates with a payor. Our patient accounting system calculates contractual allowances on a patient-by-patient basis based on the rates in effect for each primary third-party payor. Other factors that are considered and could further influence the level of our reserves include the patient’s total length of stay for in-house patients, each patient’s discharge destination, the proportion of patients with secondary insurance coverage and the level of reimbursement under that secondary coverage, and the amount of charges that will be disallowed by payors. Such additional factors are assumed to remain consistent with the experience for patients discharged in similar time periods for the same payor classes, and additional reserves are provided to account for these factors. Payors include federal and state agencies, including Medicare and Medicaid, managed care health plans, commercial insurance companies, employers, and patients.</font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Management continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care contractual terms that result from contract renegotiations and renewals. Due to complexities involved in determining amounts ultimately due under reimbursement arrangements with third-party payors, which are often subject to interpretation, we may receive reimbursement for healthcare services authorized and provided that is different from our estimates, and such differences could be material. In addition, laws and regulations governing the Medicare and Medicaid programs are complex, subject to interpretation, and are routinely modified for provider reimbursement. All healthcare providers participating in the Medicare and Medicaid programs are required to meet certain financial reporting requirements. Federal regulations require submission of annual cost reports covering medical costs and expenses associated with the services provided by each hospital to program beneficiaries. Annual cost reports required under the Medicare and Medicaid programs are subject to routine audits, which may result in adjustments to the amounts ultimately determined to be due to HealthSouth under these reimbursement programs. These audits often require several years to reach the final determination of amounts earned under the programs. If actual results are not consistent with our assumptions and judgments, we may be exposed to gains or losses that could be material.</font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">CMS has been granted authority to suspend payments, in whole or in part, to Medicare providers if CMS possesses reliable information an overpayment, fraud, or willful misrepresentation exists. If CMS suspects payments are being made as the result of fraud or misrepresentation, CMS may suspend payment at any time without providing prior notice to us. The initial suspension period is limited to </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">180</font><font style="font-family:inherit;font-size:10pt;"> days. However, the payment suspension period can be extended almost indefinitely if the matter is under investigation by the United States Department of Health and Human Services Office of Inspector General (the "HHS-OIG") or the United States Department of Justice. Therefore, we are unable to predict if or when we may be subject to a suspension of payments by the Medicare and/or Medicaid programs, the possible length of the suspension period, or the potential cash flow impact of a payment suspension. Any such suspension would adversely impact our financial position, results of operations, and cash flows.</font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We provide care to patients who are financially unable to pay for the healthcare services they receive, and because we do not pursue collection of amounts determined to qualify as charity care, such amounts are not recorded as revenues.</font></div></div>
CY2011Q4	us-gaap	Self Insurance Reserve SelfInsuranceReserve	153300000	USD
CY2010Q4	us-gaap	Self Insurance Reserve SelfInsuranceReserve	152900000	USD
CY2010Q4	us-gaap	Self Insurance Reserve Current SelfInsuranceReserveCurrent	50400000	USD
CY2011Q4	us-gaap	Self Insurance Reserve Current SelfInsuranceReserveCurrent	50500000	USD
CY2010Q4	us-gaap	Self Insurance Reserve Noncurrent SelfInsuranceReserveNoncurrent	102500000	USD
CY2011Q4	us-gaap	Self Insurance Reserve Noncurrent SelfInsuranceReserveNoncurrent	102800000	USD
CY2009	us-gaap	Share Based Compensation ShareBasedCompensation	13400000	USD
CY2010	us-gaap	Share Based Compensation ShareBasedCompensation	16400000	USD
CY2011	us-gaap	Share Based Compensation ShareBasedCompensation	20300000	USD
CY2010	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000
CY2011	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000
CY2009	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000
CY2009	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Term ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTerm	6.5	Y
CY2010	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Term ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTerm	6.7	Y
CY2011	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Term ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTerm	6.7	Y
CY2009	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.027
CY2011	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.028
CY2010	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.031
CY2011	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.415
CY2010	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.447
CY2009	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.450
CY2011Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1989000	shares
CY2011Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	22.34
CY2011	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	65000	shares
CY2011	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	0	shares
CY2011	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	200000	shares
CY2011Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	3100000	USD
CY2011Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2439000	shares
CY2010Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2493000	shares
CY2011Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	21.63
CY2010Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	22.36
CY2011Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	2200000	USD
CY2011Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1	5.3	Y
CY2011Q4	us-gaap	Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit	400000	USD
CY2011	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	189000	shares
CY2011	us-gaap	Stock Repurchase Program Authorized Amount StockRepurchaseProgramAuthorizedAmount	125000000	USD
CY2011Q4	us-gaap	Stockholders Equity StockholdersEquity	117000000	USD
CY2010Q4	us-gaap	Stockholders Equity StockholdersEquity	-85200000	USD
CY2010Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-2200000	USD
CY2011Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	201600000	USD
CY2009Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-897600000	USD
CY2008Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1087200000	USD
CY2010	us-gaap	Stockholders Equity Other StockholdersEquityOther	1300000	USD
CY2011	us-gaap	Stockholders Equity Other StockholdersEquityOther	-3900000	USD
CY2009	us-gaap	Stockholders Equity Other StockholdersEquityOther	-7000000	USD
CY2009	us-gaap	Supplies Expense SuppliesExpense	96800000	USD
CY2010	us-gaap	Supplies Expense SuppliesExpense	99400000	USD
CY2011	us-gaap	Supplies Expense SuppliesExpense	102800000	USD
CY2011Q4	us-gaap	Temporary Equity Carrying Amount TemporaryEquityCarryingAmount	387400000	USD
CY2010Q4	us-gaap	Temporary Equity Carrying Amount TemporaryEquityCarryingAmount	387400000	USD
CY2011Q4	us-gaap	Temporary Equity Liquidation Preference Per Share TemporaryEquityLiquidationPreferencePerShare	1000
CY2010Q4	us-gaap	Temporary Equity Liquidation Preference Per Share TemporaryEquityLiquidationPreferencePerShare	1000
CY2010Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.10
CY2011Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.10
CY2011Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	1500000	shares
CY2010Q4	us-gaap	Treasury Stock Value TreasuryStockValue	141800000	USD
CY2011Q4	us-gaap	Treasury Stock Value TreasuryStockValue	148800000	USD
CY2010Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	1500000	shares
CY2006Q1	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	400000	shares
CY2011Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	400000	shares
CY2010Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	400000	shares
CY2010Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	4180025	shares
CY2011Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	4489079	shares
CY2009Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	50900000	USD
CY2011Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	6000000	USD
CY2008Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	61100000	USD
CY2010Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	12600000	USD
CY2011	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	3000000	USD
CY2010	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	37500000	USD
CY2011	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	20200000	USD
CY2009	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	8500000	USD
CY2010	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	93000000	USD
CY2011Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	100000	USD
CY2008Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	2900000	USD
CY2010Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	1100000	USD
CY2009Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	1900000	USD
CY2010	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	96100000	USD
CY2011	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	19800000	USD
CY2009	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	100000	USD
CY2009	us-gaap	Unrecognized Tax Benefits Increases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities	2700000	USD
CY2011	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	3200000	USD
CY2009	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	4500000	USD
CY2010	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	3900000	USD
CY2011Q4	us-gaap	Unrecorded Unconditional Purchase Obligation Balance On Fifth Anniversary UnrecordedUnconditionalPurchaseObligationBalanceOnFifthAnniversary	20300000	USD
CY2011Q4	us-gaap	Unrecorded Unconditional Purchase Obligation Balance On First Anniversary UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary	23200000	USD
CY2011Q4	us-gaap	Unrecorded Unconditional Purchase Obligation Balance On Fourth Anniversary UnrecordedUnconditionalPurchaseObligationBalanceOnFourthAnniversary	22300000	USD
CY2011Q4	us-gaap	Unrecorded Unconditional Purchase Obligation Balance On Second Anniversary UnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary	23000000	USD
CY2011Q4	us-gaap	Unrecorded Unconditional Purchase Obligation Balance On Third Anniversary UnrecordedUnconditionalPurchaseObligationBalanceOnThirdAnniversary	18700000	USD
CY2011Q4	us-gaap	Unrecorded Unconditional Purchase Obligation Due After Five Years UnrecordedUnconditionalPurchaseObligationDueAfterFiveYears	43000000	USD
CY2011	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Use of Estimates and Assumptions—</font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of our consolidated financial statements in conformity with GAAP requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting periods. Significant estimates and assumptions are used for, but not limited to: (1) allowance for contractual revenue adjustments; (2) allowance for doubtful accounts; (3) asset impairments, including goodwill; (4) depreciable lives of assets; (5) useful lives of intangible assets; (6) economic lives and fair value of leased assets; (7) income tax valuation allowances; (8) uncertain tax positions; (9) fair value of stock options and restricted stock containing a market condition; (10) fair value of interest rate swaps; (11) reserves for professional, workers’ compensation, and comprehensive general insurance liability risks; and (12) contingency and litigation reserves. Future events and their effects cannot be predicted with certainty; accordingly, our accounting estimates require the exercise of judgment. The accounting estimates used in the preparation of our consolidated financial statements will change as new events occur, as more experience is acquired, as additional information is obtained, and as our operating environment changes. We evaluate and update our assumptions and estimates on an ongoing basis and may employ outside experts to assist in our evaluation, as considered necessary. Actual results could differ from those estimates.</font></div></div>
CY2010	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	825400000	USD
CY2009	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	76900000	USD
CY2011	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	62400000	USD
CY2009	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	-28200000	USD
CY2011	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	-22300000	USD
CY2010	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	-23800000	USD
CY2010	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	15700000	shares
CY2011	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	15900000	shares
CY2009	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	14500000	shares
CY2010	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	108500000	shares
CY2011	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	109200000	shares
CY2009	hls	Disposal Group Including Discontinued Operations Provision For Doutbtful Accounts DisposalGroupIncludingDiscontinuedOperationsProvisionForDoutbtfulAccounts	3000000	USD
CY2011	hls	Disposal Group Including Discontinued Operations Provision For Doutbtful Accounts DisposalGroupIncludingDiscontinuedOperationsProvisionForDoutbtfulAccounts	1500000	USD
CY2009	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	103300000	shares
CY2009	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	88800000	shares
CY2011	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	93300000	shares
CY2010	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	92800000	shares
CY2011Q4	hls	Adjusted Market Basket Update AdjustedMarketBasketUpdate	0.028
CY2011Q4	hls	Adjustment To Market Basket Update AdjustmentToMarketBasketUpdate	0.001
CY2009	hls	Adjustment To Other Current Liabilities AdjustmentToOtherCurrentLiabilities	4700000	USD
CY2010Q4	hls	Allowance For Doubtful Accounts As Percentage Of Patient Accounts Receivable AllowanceForDoubtfulAccountsAsPercentageOfPatientAccountsReceivable	0.103
CY2011Q4	hls	Allowance For Doubtful Accounts As Percentage Of Patient Accounts Receivable AllowanceForDoubtfulAccountsAsPercentageOfPatientAccountsReceivable	0.092
CY2011Q4	hls	Annual Payment Update Factor Reduction AnnualPaymentUpdateFactorReduction	0.02
CY2009Q4	hls	Cash And Cash Equivalents Of Facilities In Discontinued Operations Ending Balance CashAndCashEquivalentsOfFacilitiesInDiscontinuedOperationsEndingBalance	-300000	USD
CY2011Q4	hls	Cash And Cash Equivalents Of Facilities In Discontinued Operations Ending Balance CashAndCashEquivalentsOfFacilitiesInDiscontinuedOperationsEndingBalance	0	USD
CY2010Q4	hls	Cash And Cash Equivalents Of Facilities In Discontinued Operations Ending Balance CashAndCashEquivalentsOfFacilitiesInDiscontinuedOperationsEndingBalance	-100000	USD
CY2009Q4	hls	Cash And Cash Equivalents Of Facilities In Discontinuted Operations Beginning Balance CashAndCashEquivalentsOfFacilitiesInDiscontinutedOperationsBeginningBalance	300000	USD
CY2010Q4	hls	Cash And Cash Equivalents Of Facilities In Discontinuted Operations Beginning Balance CashAndCashEquivalentsOfFacilitiesInDiscontinutedOperationsBeginningBalance	100000	USD
CY2008Q4	hls	Cash And Cash Equivalents Of Facilities In Discontinuted Operations Beginning Balance CashAndCashEquivalentsOfFacilitiesInDiscontinutedOperationsBeginningBalance	500000	USD
CY2009	hls	Common Stock Issued Under Securities Litigation Settlement CommonStockIssuedUnderSecuritiesLitigationSettlement	111800000	USD
CY2009Q3	hls	Common Stock Shares Issued Consolidated Securities Action Settlement CommonStockSharesIssuedConsolidatedSecuritiesActionSettlement	5000000	shares
CY2009Q3	hls	Common Stock Warrants Issued Consolidated Securities Action Settlement CommonStockWarrantsIssuedConsolidatedSecuritiesActionSettlement	8200000	shares
CY2011Q4	hls	Compliance Threshold Under Health Care Act ComplianceThresholdUnderHealthCareAct	0.60
CY2011Q4	hls	Convertible Preferred Stock Conversion Price ConvertiblePreferredStockConversionPrice	30.50
CY2009	hls	Debt Amendment And Issuance Costs DebtAmendmentAndIssuanceCosts	10600000	USD
CY2010	hls	Debt Amendment And Issuance Costs DebtAmendmentAndIssuanceCosts	19300000	USD
CY2011	hls	Debt Amendment And Issuance Costs DebtAmendmentAndIssuanceCosts	4400000	USD
CY2011Q4	hls	Deferred Tax Asset Property Plant And Equipment DeferredTaxAssetPropertyPlantAndEquipment	49800000	USD
CY2010Q4	hls	Deferred Tax Asset Property Plant And Equipment DeferredTaxAssetPropertyPlantAndEquipment	49100000	USD
CY2011Q4	hls	Deferred Tax Assets Intangible Assets DeferredTaxAssetsIntangibleAssets	0	USD
CY2010Q4	hls	Deferred Tax Assets Intangible Assets DeferredTaxAssetsIntangibleAssets	9600000	USD
CY2010	hls	Disposal Group Including Discontinued Operations Net Operating Revenues Less Provision For Doubtful Accounts DisposalGroupIncludingDiscontinuedOperationsNetOperatingRevenuesLessProvisionForDoubtfulAccounts	121300000	USD
CY2009	hls	Disposal Group Including Discontinued Operations Net Operating Revenues Less Provision For Doubtful Accounts DisposalGroupIncludingDiscontinuedOperationsNetOperatingRevenuesLessProvisionForDoubtfulAccounts	141000000	USD
CY2011	hls	Disposal Group Including Discontinued Operation Impairments DisposalGroupIncludingDiscontinuedOperationImpairments	6800000	USD
CY2009	hls	Disposal Group Including Discontinued Operation Impairments DisposalGroupIncludingDiscontinuedOperationImpairments	4000000	USD
CY2010	hls	Disposal Group Including Discontinued Operation Impairments DisposalGroupIncludingDiscontinuedOperationImpairments	600000	USD
CY2011	hls	Disposal Group Including Discontinued Operations Net Operating Revenues Less Provision For Doubtful Accounts DisposalGroupIncludingDiscontinuedOperationsNetOperatingRevenuesLessProvisionForDoubtfulAccounts	94200000	USD
CY2010	hls	Disposal Group Including Discontinued Operations Provision For Doutbtful Accounts DisposalGroupIncludingDiscontinuedOperationsProvisionForDoutbtfulAccounts	2400000	USD
CY2011	hls	Income Loss From Continuing Operations Attributable To Common Shareholders Diluted IncomeLossFromContinuingOperationsAttributableToCommonShareholdersDiluted	158800000	USD
CY2010	hls	Effective Income Tax Rate Reconciliation Net Interest EffectiveIncomeTaxRateReconciliationNetInterest	-0.008
CY2009	hls	Effective Income Tax Rate Reconciliation Net Interest EffectiveIncomeTaxRateReconciliationNetInterest	-0.012
CY2011	hls	Effective Income Tax Rate Reconciliation Net Interest EffectiveIncomeTaxRateReconciliationNetInterest	-0.016
CY2011	hls	Effective Income Tax Rate Reconciliation Net Operating Loss Carryforward Adjustments EffectiveIncomeTaxRateReconciliationNetOperatingLossCarryforwardAdjustments	0.029
CY2010	hls	Effective Income Tax Rate Reconciliation Net Operating Loss Carryforward Adjustments EffectiveIncomeTaxRateReconciliationNetOperatingLossCarryforwardAdjustments	0.000
CY2009	hls	Effective Income Tax Rate Reconciliation Net Operating Loss Carryforward Adjustments EffectiveIncomeTaxRateReconciliationNetOperatingLossCarryforwardAdjustments	0.000
CY2009	hls	Equity In Net Income Of Consolidated Affiliates EquityInNetIncomeOfConsolidatedAffiliates	0	USD
CY2011	hls	Equity In Net Income Of Consolidated Affiliates EquityInNetIncomeOfConsolidatedAffiliates	0	USD
CY2010	hls	Equity In Net Income Of Consolidated Affiliates EquityInNetIncomeOfConsolidatedAffiliates	0	USD
CY2011	hls	Equity Method Investment Summarized Financial Information Operating Expenses EquityMethodInvestmentSummarizedFinancialInformationOperatingExpenses	-53100000	USD
CY2010	hls	Equity Method Investment Summarized Financial Information Operating Expenses EquityMethodInvestmentSummarizedFinancialInformationOperatingExpenses	-51600000	USD
CY2009	hls	Equity Method Investment Summarized Financial Information Operating Expenses EquityMethodInvestmentSummarizedFinancialInformationOperatingExpenses	-47200000	USD
CY2010Q4	hls	Equity Method Investments Cumulative Share Of Distributions EquityMethodInvestmentsCumulativeShareOfDistributions	-67100000	USD
CY2011Q4	hls	Equity Method Investments Cumulative Share Of Distributions EquityMethodInvestmentsCumulativeShareOfDistributions	-80100000	USD
CY2010Q4	hls	Equity Method Investments Cumulative Share Of Income EquityMethodInvestmentsCumulativeShareOfIncome	88000000	USD
CY2011Q4	hls	Equity Method Investments Cumulative Share Of Income EquityMethodInvestmentsCumulativeShareOfIncome	100000000	USD
CY2011	hls	Estimated Ultimate Losses Reduction Related To Prior Loss Periods EstimatedUltimateLossesReductionRelatedToPriorLossPeriods	4400000	USD
CY2010	hls	Estimated Ultimate Losses Reduction Related To Prior Loss Periods EstimatedUltimateLossesReductionRelatedToPriorLossPeriods	1700000	USD
CY2009	hls	Estimated Ultimate Losses Reduction Related To Prior Loss Periods EstimatedUltimateLossesReductionRelatedToPriorLossPeriods	7400000	USD
CY2011Q4	hls	Fully Depreciated Assets FullyDepreciatedAssets	221900000	USD
CY2010Q4	hls	Fully Depreciated Assets FullyDepreciatedAssets	200800000	USD
CY2009	hls	Gain Loss On Disposition Of Assets Discontinued Operations GainLossOnDispositionOfAssetsDiscontinuedOperations	300000	USD
CY2011	hls	Gain Loss On Disposition Of Assets Discontinued Operations GainLossOnDispositionOfAssetsDiscontinuedOperations	0	USD
CY2010	hls	Gain Loss On Disposition Of Assets Discontinued Operations GainLossOnDispositionOfAssetsDiscontinuedOperations	-1200000	USD
CY2009	hls	Government Class Action And Related Settlements Cf GovernmentClassActionAndRelatedSettlementsCf	-11200000	USD
CY2010	hls	Government Class Action And Related Settlements Cf GovernmentClassActionAndRelatedSettlementsCf	-2900000	USD
CY2011	hls	Government Class Action And Related Settlements Cf GovernmentClassActionAndRelatedSettlementsCf	8500000	USD
CY2010	hls	Government Class Action And Related Settlements Expense GovernmentClassActionAndRelatedSettlementsExpense	1100000	USD
CY2011	hls	Government Class Action And Related Settlements Expense GovernmentClassActionAndRelatedSettlementsExpense	-12300000	USD
CY2009	hls	Government Class Action And Related Settlements Expense GovernmentClassActionAndRelatedSettlementsExpense	36700000	USD
CY2011Q4	hls	Guarantees Maximum Term GuaranteesMaximumTerm	90	M
CY2011Q4	hls	Guarantees Minimum Term GuaranteesMinimumTerm	1	M
CY2009	hls	Healthcare Plan Expense HealthcarePlanExpense	59000000	USD
CY2010	hls	Healthcare Plan Expense HealthcarePlanExpense	59700000	USD
CY2011	hls	Healthcare Plan Expense HealthcarePlanExpense	66800000	USD
CY2009	hls	Income Loss From Continuing Operations Attributable To Common Shareholders Basic IncomeLossFromContinuingOperationsAttributableToCommonShareholdersBasic	51100000	USD
CY2010	hls	Income Loss From Continuing Operations Attributable To Common Shareholders Basic IncomeLossFromContinuingOperationsAttributableToCommonShareholdersBasic	863800000	USD
CY2011	hls	Income Loss From Continuing Operations Attributable To Common Shareholders Basic IncomeLossFromContinuingOperationsAttributableToCommonShareholdersBasic	132800000	USD
CY2010	hls	Income Loss From Continuing Operations Attributable To Common Shareholders Diluted IncomeLossFromContinuingOperationsAttributableToCommonShareholdersDiluted	889800000	USD
CY2009	hls	Income Loss From Continuing Operations Attributable To Common Shareholders Diluted IncomeLossFromContinuingOperationsAttributableToCommonShareholdersDiluted	77100000	USD
CY2010	hls	Increase Decrease In Accrued Fees And Expenses For Derivative Plaintiffs Attorneys IncreaseDecreaseInAccruedFeesAndExpensesForDerivativePlaintiffsAttorneys	0	USD
CY2009	hls	Increase Decrease In Accrued Fees And Expenses For Derivative Plaintiffs Attorneys IncreaseDecreaseInAccruedFeesAndExpensesForDerivativePlaintiffsAttorneys	-26200000	USD
CY2011	hls	Increase Decrease In Accrued Fees And Expenses For Derivative Plaintiffs Attorneys IncreaseDecreaseInAccruedFeesAndExpensesForDerivativePlaintiffsAttorneys	0	USD
CY2010	hls	Increase Decrease In Refunds Due Patients And Other Third Party Payors IncreaseDecreaseInRefundsDuePatientsAndOtherThirdPartyPayors	-3400000	USD
CY2009	hls	Increase Decrease In Refunds Due Patients And Other Third Party Payors IncreaseDecreaseInRefundsDuePatientsAndOtherThirdPartyPayors	3900000	USD
CY2011	hls	Increase Decrease In Refunds Due Patients And Other Third Party Payors IncreaseDecreaseInRefundsDuePatientsAndOtherThirdPartyPayors	-16200000	USD
CY2011Q4	hls	Initial Suspension Period Medicare Payments InitialSuspensionPeriodMedicarePayments	180	D
CY2011	hls	Interest Rate Swaps Initial Net Investment InterestRateSwapsInitialNetInvestment	0	USD
CY2009	hls	Interest Rate Swaps Initial Net Investment InterestRateSwapsInitialNetInvestment	6400000	USD
CY2010	hls	Interest Rate Swaps Initial Net Investment InterestRateSwapsInitialNetInvestment	0	USD
CY2010Q4	hls	Investments Total InvestmentsTotal	122300000	USD
CY2011Q4	hls	Investments Total InvestmentsTotal	110600000	USD
CY2011Q3	hls	Long Lived Assets Held For Sale Purchase Price LongLivedAssetsHeldForSalePurchasePrice	117500000	USD
CY2011Q2	hls	Long Lived Assets Held For Sale Purchase Price LongLivedAssetsHeldForSalePurchasePrice	120000000	USD
CY2011Q4	hls	Market Basket Update MarketBasketUpdate	0.029
CY2011Q4	hls	Maximum Self Insured Risk MaximumSelfInsuredRisk	24000000	USD
CY2011Q4	hls	Medicare Denials Percentage Collected After Appeal MedicareDenialsPercentageCollectedAfterAppeal	0.58
CY2011Q4	hls	Medicare Physician Reimbursement Adjustment MedicarePhysicianReimbursementAdjustment	0.27
CY2011Q4	hls	Medicare Productivity Adjustment MedicareProductivityAdjustment	0.010
CY2011Q4	hls	Minimum Amount Of Loss Contingency To Consider When Accruing Estimate Of Related Legal Fees MinimumAmountOfLossContingencyToConsiderWhenAccruingEstimateOfRelatedLegalFees	5000000	USD
CY2009	hls	Net Operating Revenues Less Provision For Doubtful Accounts NetOperatingRevenuesLessProvisionForDoubtfulAccounts	1754200000	USD
CY2011	hls	Net Operating Revenues Less Provision For Doubtful Accounts NetOperatingRevenuesLessProvisionForDoubtfulAccounts	2005900000	USD
CY2010	hls	Net Operating Revenues Less Provision For Doubtful Accounts NetOperatingRevenuesLessProvisionForDoubtfulAccounts	1861200000	USD
CY2011	hls	Number Of Freestanding Ltchs NumberOfFreestandingLtchs	6	facilities
CY2011Q4	hls	Number Of General Or Limited Partnerships Limited Liability Companies Or Joint Ventures NumberOfGeneralOrLimitedPartnershipsLimitedLiabilityCompaniesOrJointVentures	10	facilities
CY2011Q4	hls	Number Of Guarantees NumberOfGuarantees	23
CY2011Q4	hls	Number Of Hospital Based Home Health Agencies NumberOfHospitalBasedHomeHealthAgencies	25	facilities
CY2011Q4	hls	Number Of Hospitals Sole Ownership NumberOfHospitalsSoleOwnership	70	facilities
CY2011Q4	hls	Number Of Individual Claims Covered By Self Insured Risk Reserves NumberOfIndividualClaimsCoveredBySelfInsuredRiskReserves	800
CY2010Q4	hls	Number Of Individual Claims Covered By Self Insured Risk Reserves NumberOfIndividualClaimsCoveredBySelfInsuredRiskReserves	800
CY2011Q4	hls	Number Of Inpatient Rehabilitation Hospitals NumberOfInpatientRehabilitationHospitals	99	facilities
CY2011Q4	hls	Number Of Inpatient Rehabilitation Units Under Management Contracts NumberOfInpatientRehabilitationUnitsUnderManagementContracts	3
CY2011Q4	hls	Number Of Joint Venture Hospitals Accounted For Using Equity Method NumberOfJointVentureHospitalsAccountedForUsingEquityMethod	3	facilities
CY2011Q4	hls	Number Of Joint Venture Outpatient Rehabilitation Satellite Clinics NumberOfJointVentureOutpatientRehabilitationSatelliteClinics	1	facilities
CY2011Q4	hls	Number Of Jointly Owned Hospitals NumberOfJointlyOwnedHospitals	29	facilities
CY2011	hls	Number Of Long Term Acute Care Hospitals Reclassified NumberOfLongTermAcuteCareHospitalsReclassified	6	facilities
CY2011	hls	Number Of Long Term Acute Care Hospitals Sold NumberOfLongTermAcuteCareHospitalsSold	5	facilities
CY2011Q4	hls	Number Of Outpatient Rehabilitation Satellite Clinics NumberOfOutpatientRehabilitationSatelliteClinics	26	facilities
CY2011Q4	hls	Number Of Partially Owned Subsidiaries Nonconsolidated NumberOfPartiallyOwnedSubsidiariesNonconsolidated	14	facilities
CY2011Q4	hls	Number Of Sale Leaseback Transactions NumberOfSaleLeasebackTransactions	2
CY2011	hls	Occupancy Cost OccupancyCost	48400000	USD
CY2010	hls	Occupancy Cost OccupancyCost	44900000	USD
CY2009	hls	Occupancy Cost OccupancyCost	44900000	USD
CY2011Q4	hls	Operating And Capital Leases Future Minimum Payments Due OperatingAndCapitalLeasesFutureMinimumPaymentsDue	388300000	USD
CY2011Q4	hls	Operating And Capital Leases Future Minimum Payments Due Current OperatingAndCapitalLeasesFutureMinimumPaymentsDueCurrent	57300000	USD
CY2011Q4	hls	Operating And Capital Leases Future Minimum Payments Due In Five Years OperatingAndCapitalLeasesFutureMinimumPaymentsDueInFiveYears	31200000	USD
CY2011Q4	hls	Operating And Capital Leases Future Minimum Payments Due In Four Years OperatingAndCapitalLeasesFutureMinimumPaymentsDueInFourYears	37000000	USD
CY2011Q4	hls	Operating And Capital Leases Future Minimum Payments Due In Three Years OperatingAndCapitalLeasesFutureMinimumPaymentsDueInThreeYears	43000000	USD
CY2011Q4	hls	Operating And Capital Leases Future Minimum Payments Due In Two Years OperatingAndCapitalLeasesFutureMinimumPaymentsDueInTwoYears	53400000	USD
CY2011Q4	hls	Operating And Capital Leases Future Minimum Payments Due Thereafter OperatingAndCapitalLeasesFutureMinimumPaymentsDueThereafter	166400000	USD
CY2010Q1	hls	Operating Earnings OperatingEarnings	76300000	USD
CY2010Q3	hls	Operating Earnings OperatingEarnings	67100000	USD
CY2010	hls	Operating Earnings OperatingEarnings	295900000	USD
CY2010Q4	hls	Operating Earnings OperatingEarnings	81400000	USD
CY2010Q2	hls	Operating Earnings OperatingEarnings	71100000	USD
CY2011	hls	Operating Earnings OperatingEarnings	351400000	USD
CY2011Q3	hls	Operating Earnings OperatingEarnings	79100000	USD
CY2011Q1	hls	Operating Earnings OperatingEarnings	89300000	USD
CY2011Q2	hls	Operating Earnings OperatingEarnings	90900000	USD
CY2011Q4	hls	Operating Earnings OperatingEarnings	92100000	USD
CY2011Q4	hls	Operating Lease Term Maximum OperatingLeaseTermMaximum	15	Y
CY2011Q4	hls	Operating Lease Term Minimum OperatingLeaseTermMinimum	3	Y
CY2011	hls	Operating Leases Rent Expense Other OperatingLeasesRentExpenseOther	4200000	USD
CY2009	hls	Operating Leases Rent Expense Other OperatingLeasesRentExpenseOther	4200000	USD
CY2010	hls	Operating Leases Rent Expense Other OperatingLeasesRentExpenseOther	4700000	USD
CY2011	hls	Other Investing Activities Of Discontinued Operations OtherInvestingActivitiesOfDiscontinuedOperations	700000	USD
CY2010	hls	Other Investing Activities Of Discontinued Operations OtherInvestingActivitiesOfDiscontinuedOperations	-6900000	USD
CY2009	hls	Other Investing Activities Of Discontinued Operations OtherInvestingActivitiesOfDiscontinuedOperations	1400000	USD
CY2010	hls	Other Net OtherNet	4500000	USD
CY2011	hls	Other Net OtherNet	15400000	USD
CY2009	hls	Other Net OtherNet	300000	USD
CY2008Q4	hls	Overstatement Of Investment In Joint Venture Hospital Prior Period OverstatementOfInvestmentInJointVentureHospitalPriorPeriod	9600000	USD
CY2011	hls	Ownership Percentage Of Subsidiary Guarantors OwnershipPercentageOfSubsidiaryGuarantors	1.00
CY2010Q4	hls	Patient Accounts Receivable Gross Current PatientAccountsReceivableGrossCurrent	219700000	USD
CY2011Q4	hls	Patient Accounts Receivable Gross Current PatientAccountsReceivableGrossCurrent	232500000	USD
CY2010Q4	hls	Patient Accounts Receivable Net Current PatientAccountsReceivableNetCurrent	197000000	USD
CY2011Q4	hls	Patient Accounts Receivable Net Current PatientAccountsReceivableNetCurrent	211100000	USD
CY2009	hls	Payments Liability Claims Net Of Reinsurance Recoveries PaymentsLiabilityClaimsNetOfReinsuranceRecoveries	26800000	USD
CY2010	hls	Payments Liability Claims Net Of Reinsurance Recoveries PaymentsLiabilityClaimsNetOfReinsuranceRecoveries	30700000	USD
CY2011	hls	Payments Liability Claims Net Of Reinsurance Recoveries PaymentsLiabilityClaimsNetOfReinsuranceRecoveries	27000000	USD
CY2009	hls	Percentage Of Net Operating Revenues Managed Care PercentageOfNetOperatingRevenuesManagedCare	0.230
CY2010	hls	Percentage Of Net Operating Revenues Managed Care PercentageOfNetOperatingRevenuesManagedCare	0.213
CY2011	hls	Percentage Of Net Operating Revenues Managed Care PercentageOfNetOperatingRevenuesManagedCare	0.198
CY2010	hls	Percentage Of Net Operating Revenues Medicaid PercentageOfNetOperatingRevenuesMedicaid	0.018
CY2009	hls	Percentage Of Net Operating Revenues Medicaid PercentageOfNetOperatingRevenuesMedicaid	0.022
CY2011	hls	Percentage Of Net Operating Revenues Medicaid PercentageOfNetOperatingRevenuesMedicaid	0.016
CY2009	hls	Percentage Of Net Operating Revenues Medicare PercentageOfNetOperatingRevenuesMedicare	0.678
CY2011	hls	Percentage Of Net Operating Revenues Medicare PercentageOfNetOperatingRevenuesMedicare	0.720
CY2010	hls	Percentage Of Net Operating Revenues Medicare PercentageOfNetOperatingRevenuesMedicare	0.705
CY2011	hls	Percentage Of Net Operating Revenues Other Income PercentageOfNetOperatingRevenuesOtherIncome	0.018
CY2009	hls	Percentage Of Net Operating Revenues Other Income PercentageOfNetOperatingRevenuesOtherIncome	0.014
CY2010	hls	Percentage Of Net Operating Revenues Other Income PercentageOfNetOperatingRevenuesOtherIncome	0.012
CY2011	hls	Percentage Of Net Operating Revenues Other Third Party Payors PercentageOfNetOperatingRevenuesOtherThirdPartyPayors	0.020
CY2010	hls	Percentage Of Net Operating Revenues Other Third Party Payors PercentageOfNetOperatingRevenuesOtherThirdPartyPayors	0.023
CY2009	hls	Percentage Of Net Operating Revenues Other Third Party Payors PercentageOfNetOperatingRevenuesOtherThirdPartyPayors	0.026
CY2009	hls	Percentage Of Net Operating Revenues Patients PercentageOfNetOperatingRevenuesPatients	0.013
CY2010	hls	Percentage Of Net Operating Revenues Patients PercentageOfNetOperatingRevenuesPatients	0.013
CY2011	hls	Percentage Of Net Operating Revenues Patients PercentageOfNetOperatingRevenuesPatients	0.012
CY2010	hls	Percentage Of Net Operating Revenues Total PercentageOfNetOperatingRevenuesTotal	1.000
CY2011	hls	Percentage Of Net Operating Revenues Total PercentageOfNetOperatingRevenuesTotal	1.000
CY2009	hls	Percentage Of Net Operating Revenues Total PercentageOfNetOperatingRevenuesTotal	1.000
CY2011	hls	Percentage Of Net Operating Revenues Workers Compensation PercentageOfNetOperatingRevenuesWorkersCompensation	0.016
CY2010	hls	Percentage Of Net Operating Revenues Workers Compensation PercentageOfNetOperatingRevenuesWorkersCompensation	0.016
CY2009	hls	Percentage Of Net Operating Revenues Workers Compensation PercentageOfNetOperatingRevenuesWorkersCompensation	0.017
CY2010Q4	hls	Percentage Of Net Patient Service Accounts Receivable PercentageOfNetPatientServiceAccountsReceivable	1.000
CY2011Q4	hls	Percentage Of Net Patient Service Accounts Receivable PercentageOfNetPatientServiceAccountsReceivable	1.000
CY2010Q4	hls	Percentage Of Net Patient Service Accounts Receivable Managed Care And Other Discount Plans PercentageOfNetPatientServiceAccountsReceivableManagedCareAndOtherDiscountPlans	0.289
CY2011Q4	hls	Percentage Of Net Patient Service Accounts Receivable Managed Care And Other Discount Plans PercentageOfNetPatientServiceAccountsReceivableManagedCareAndOtherDiscountPlans	0.268
CY2011Q4	hls	Percentage Of Net Patient Service Accounts Receivable Medicaid PercentageOfNetPatientServiceAccountsReceivableMedicaid	0.026
CY2010Q4	hls	Percentage Of Net Patient Service Accounts Receivable Medicaid PercentageOfNetPatientServiceAccountsReceivableMedicaid	0.022
CY2010Q4	hls	Percentage Of Net Patient Service Accounts Receivable Medicare PercentageOfNetPatientServiceAccountsReceivableMedicare	0.587
CY2010Q4	hls	Percentage Of Net Patient Service Accounts Receivable Workers Compensation PercentageOfNetPatientServiceAccountsReceivableWorkersCompensation	0.031
CY2011Q4	hls	Percentage Of Net Patient Service Accounts Receivable Medicare PercentageOfNetPatientServiceAccountsReceivableMedicare	0.607
CY2010Q4	hls	Percentage Of Net Patient Service Accounts Receivable Other Third Party Payors PercentageOfNetPatientServiceAccountsReceivableOtherThirdPartyPayors	0.050
CY2011Q4	hls	Percentage Of Net Patient Service Accounts Receivable Other Third Party Payors PercentageOfNetPatientServiceAccountsReceivableOtherThirdPartyPayors	0.047
CY2010Q4	hls	Percentage Of Net Patient Service Accounts Receivable Patients PercentageOfNetPatientServiceAccountsReceivablePatients	0.021
CY2011Q4	hls	Percentage Of Net Patient Service Accounts Receivable Patients PercentageOfNetPatientServiceAccountsReceivablePatients	0.020
CY2011Q4	hls	Percentage Of Net Patient Service Accounts Receivable Workers Compensation PercentageOfNetPatientServiceAccountsReceivableWorkersCompensation	0.032
CY2008Q1	hls	Percentage Of Net Profit Due Company From Hospital Building Sale PercentageOfNetProfitDueCompanyFromHospitalBuildingSale	0.40
CY2011Q4	hls	Percentage Of Ownership In Jointly Owned Hospitals Maximum PercentageOfOwnershipInJointlyOwnedHospitalsMaximum	0.975
CY2011Q4	hls	Percentage Of Ownership In Jointly Owned Hospitals Minimum PercentageOfOwnershipInJointlyOwnedHospitalsMinimum	0.500
CY2011	hls	Premium Paid On Redemption Of Bonds PremiumPaidOnRedemptionOfBonds	26900000	USD
CY2009	hls	Premium Paid On Redemption Of Bonds PremiumPaidOnRedemptionOfBonds	0	USD
CY2010	hls	Premium Paid On Redemption Of Bonds PremiumPaidOnRedemptionOfBonds	0	USD
CY2011	hls	Premium Received On Bond Issuance PremiumReceivedOnBondIssuance	4100000	USD
CY2010	hls	Premium Received On Bond Issuance PremiumReceivedOnBondIssuance	0	USD
CY2009	hls	Premium Received On Bond Issuance PremiumReceivedOnBondIssuance	0	USD
CY2010Q4	hls	Prior Period Overpayments Included In Refunds Due Patients And Other Third Party Payors Liability PriorPeriodOverpaymentsIncludedInRefundsDuePatientsAndOtherThirdPartyPayorsLiability	42100000	USD
CY2010	hls	Professional And General Liability Excess Loss Contracts Total Costs ProfessionalAndGeneralLiabilityExcessLossContractsTotalCosts	2400000	USD
CY2009	hls	Professional And General Liability Excess Loss Contracts Total Costs ProfessionalAndGeneralLiabilityExcessLossContractsTotalCosts	2900000	USD
CY2011	hls	Professional And General Liability Excess Loss Contracts Total Costs ProfessionalAndGeneralLiabilityExcessLossContractsTotalCosts	2300000	USD
CY2009	hls	Professional Fees Accounting Tax And Legal ProfessionalFeesAccountingTaxAndLegal	8800000	USD
CY2010	hls	Professional Fees Accounting Tax And Legal ProfessionalFeesAccountingTaxAndLegal	17200000	USD
CY2011	hls	Professional Fees Accounting Tax And Legal ProfessionalFeesAccountingTaxAndLegal	21000000	USD
CY2011Q4	hls	Property And Equipment Net Excluding Cip PropertyAndEquipmentNetExcludingCIP	654000000	USD
CY2010Q4	hls	Property And Equipment Net Excluding Cip PropertyAndEquipmentNetExcludingCIP	618000000	USD
CY2011	hls	Provision For Government Class Action And Related Settlements Expense ProvisionForGovernmentClassActionAndRelatedSettlementsExpense	-12300000	USD
CY2010	hls	Provision For Government Class Action And Related Settlements Expense ProvisionForGovernmentClassActionAndRelatedSettlementsExpense	1100000	USD
CY2009	hls	Provision For Government Class Action And Related Settlements Expense ProvisionForGovernmentClassActionAndRelatedSettlementsExpense	36700000	USD
CY2011Q3	hls	Reduction In Aggregate Purchase Price ReductionInAggregatePurchasePrice	2500000	USD
CY2011Q4	hls	Refunds Due Patients And Other Third Party Payors RefundsDuePatientsAndOtherThirdPartyPayors	7300000	USD
CY2010Q4	hls	Refunds Due Patients And Other Third Party Payors RefundsDuePatientsAndOtherThirdPartyPayors	48300000	USD
CY2010Q4	hls	Refunds Due Patients And Other Third Party Payors Liability Divested Divisions RefundsDuePatientsAndOtherThirdPartyPayorsLiabilityDivestedDivisions	33900000	USD
CY2011Q4	hls	Reinsurance Receivables Current ReinsuranceReceivablesCurrent	16300000	USD
CY2010Q4	hls	Reinsurance Receivables Current ReinsuranceReceivablesCurrent	14400000	USD
CY2010	hls	Reinsurance Recoveries ReinsuranceRecoveries	1000000	USD
CY2011	hls	Reinsurance Recoveries ReinsuranceRecoveries	1400000	USD
CY2009	hls	Reinsurance Recoveries ReinsuranceRecoveries	1200000	USD
CY2011	hls	Retained Professional And General Liability Risks Total Costs RetainedProfessionalAndGeneralLiabilityRisksTotalCosts	19900000	USD
CY2010	hls	Retained Professional And General Liability Risks Total Costs RetainedProfessionalAndGeneralLiabilityRisksTotalCosts	27400000	USD
CY2009	hls	Retained Professional And General Liability Risks Total Costs RetainedProfessionalAndGeneralLiabilityRisksTotalCosts	12900000	USD
CY2010	hls	Retained Workers Compensation Risks Salaries And Benefits RetainedWorkersCompensationRisksSalariesAndBenefits	7300000	USD
CY2009	hls	Retained Workers Compensation Risks Salaries And Benefits RetainedWorkersCompensationRisksSalariesAndBenefits	12800000	USD
CY2011	hls	Retained Workers Compensation Risks Salaries And Benefits RetainedWorkersCompensationRisksSalariesAndBenefits	8800000	USD
CY2011	hls	Retained Workers Compensation Risks Total Costs RetainedWorkersCompensationRisksTotalCosts	9000000	USD
CY2010	hls	Retained Workers Compensation Risks Total Costs RetainedWorkersCompensationRisksTotalCosts	7500000	USD
CY2009	hls	Retained Workers Compensation Risks Total Costs RetainedWorkersCompensationRisksTotalCosts	13100000	USD
CY2011Q4	hls	Retirement Investment Plan Age Requirement RetirementInvestmentPlanAgeRequirement	21
CY2011Q4	hls	Retirement Investment Plan Company Match RetirementInvestmentPlanCompanyMatch	50% of the first 6% of each participant’s elective deferrals
CY2010	hls	Retirement Investment Plan Company Match Funded By Plan Forfeiture Account RetirementInvestmentPlanCompanyMatchFundedByPlanForfeitureAccount	1600000	USD
CY2009	hls	Retirement Investment Plan Company Match Funded By Plan Forfeiture Account RetirementInvestmentPlanCompanyMatchFundedByPlanForfeitureAccount	1200000	USD
CY2011	hls	Retirement Investment Plan Company Match Funded By Plan Forfeiture Account RetirementInvestmentPlanCompanyMatchFundedByPlanForfeitureAccount	1700000	USD
CY2010	hls	Retirement Investment Plan Company Match Total Costs RetirementInvestmentPlanCompanyMatchTotalCosts	12000000	USD
CY2011	hls	Retirement Investment Plan Company Match Total Costs RetirementInvestmentPlanCompanyMatchTotalCosts	12400000	USD
CY2009	hls	Retirement Investment Plan Company Match Total Costs RetirementInvestmentPlanCompanyMatchTotalCosts	12200000	USD
CY2011Q4	hls	Retirement Investment Plan Company Match Vesting Percentage RetirementInvestmentPlanCompanyMatchVestingPercentage	1.00
CY2011Q4	hls	Retirement Investment Plan Company Match Vesting Period RetirementInvestmentPlanCompanyMatchVestingPeriod	3	Y
CY2011Q4	hls	Retirement Investment Plan Maximum Employee Contribution RetirementInvestmentPlanMaximumEmployeeContribution	1.00
CY2010	hls	Salaries And Benefits SalariesAndBenefits	921700000	USD
CY2011	hls	Salaries And Benefits SalariesAndBenefits	982000000	USD
CY2009	hls	Salaries And Benefits SalariesAndBenefits	887400000	USD
CY2010	hls	Securities Litigation Settlement Non Cash SecuritiesLitigationSettlementNonCash	0	USD
CY2011	hls	Securities Litigation Settlement Non Cash SecuritiesLitigationSettlementNonCash	0	USD
CY2009	hls	Securities Litigation Settlement Non Cash SecuritiesLitigationSettlementNonCash	294600000	USD
CY2010	hls	Self Insured Risks SelfInsuredRisks	7300000	USD
CY2009	hls	Self Insured Risks SelfInsuredRisks	-1600000	USD
CY2011	hls	Self Insured Risks SelfInsuredRisks	3800000	USD
CY2010	hls	Senior Management Bonus Program Total Costs SeniorManagementBonusProgramTotalCosts	11300000	USD
CY2011	hls	Senior Management Bonus Program Total Costs SeniorManagementBonusProgramTotalCosts	13000000	USD
CY2009	hls	Senior Management Bonus Program Total Costs SeniorManagementBonusProgramTotalCosts	13300000	USD
CY2011Q1	hls	Senior Notes Proceeds From Public Offering SeniorNotesProceedsFromPublicOffering	122000000	USD
CY2011Q3	hls	Sequestration Rate SequestrationRate	0.02
CY2011Q4	hls	Severance Agreements Due After Five Years SeveranceAgreementsDueAfterFiveYears	2400000	USD
CY2011Q4	hls	Severance Agreements Due Within Five Years SeveranceAgreementsDueWithinFiveYears	200000	USD
CY2011Q4	hls	Severance Agreements Due Within Four Years SeveranceAgreementsDueWithinFourYears	200000	USD
CY2011Q4	hls	Severance Agreements Due Within One Year SeveranceAgreementsDueWithinOneYear	200000	USD
CY2011Q4	hls	Severance Agreements Due Within Three Years SeveranceAgreementsDueWithinThreeYears	200000	USD
CY2011Q4	hls	Severance Agreements Due Within Two Years SeveranceAgreementsDueWithinTwoYears	200000	USD
CY2011Q4	hls	Share Based Compensation Arrangement By Share Based Payment Awards Options Exercisable Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardsOptionsExercisableWeightedAverageRemainingContractualTerm	4.6	Y
CY2011	hls	Share Based Compensation Arrangement By Share Based Payment Awards Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardsOptionsExercisesInPeriodWeightedAverageExercisePrice	23.39
CY2011	hls	Share Based Compensation Arrangement By Share Based Payment Awards Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardsOptionsExpirationsInPeriodWeightedAverageExercisePrice	52.44
CY2011	hls	Share Based Compensation Arrangement By Share Based Payment Awards Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardsOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.00
CY2011	hls	Share Based Compensation Arrangement By Share Based Payment Awards Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardsOptionsGrantsInPeriodWeightedAverageExercisePrice	24.21
CY2004Q1	hls	Stock Warrants Issued Term StockWarrantsIssuedTerm	10	Y
CY2009Q3	hls	Stock Warrants Issued Term StockWarrantsIssuedTerm	7	Y
CY2010	hls	Termination Fee Forward Starting Interest Rate Swaps TerminationFeeForwardStartingInterestRateSwaps	-6900000	USD
CY2011	hls	Termination Fee Forward Starting Interest Rate Swaps TerminationFeeForwardStartingInterestRateSwaps	0	USD
CY2009	hls	Termination Fee Forward Starting Interest Rate Swaps TerminationFeeForwardStartingInterestRateSwaps	0	USD
CY2009	hls	Understatement Of Net Income UnderstatementOfNetIncome	4500000	USD
CY2010	hls	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccruedDecreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2011	hls	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccruedDecreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2009	hls	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccruedDecreasesResultingFromSettlementsWithTaxingAuthorities	0	USD
CY2011	hls	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccruedDecreasesResultingFromSettlementsWithTaxingAuthorities	0	USD
CY2010	hls	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccruedDecreasesResultingFromSettlementsWithTaxingAuthorities	0	USD
CY2010	hls	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccruedIncreasesResultingFromPriorPeriodTaxPositions	100000	USD
CY2009	hls	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccruedIncreasesResultingFromPriorPeriodTaxPositions	100000	USD
CY2011	hls	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccruedIncreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2009	hls	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued Increases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccruedIncreasesResultingFromSettlementsWithTaxingAuthorities	0	USD
CY2010	hls	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccruedReductionsResultingFromLapseOfApplicableStatuteOfLimitations	900000	USD
CY2011	hls	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccruedReductionsResultingFromLapseOfApplicableStatuteOfLimitations	1000000	USD
CY2009	hls	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccruedReductionsResultingFromLapseOfApplicableStatuteOfLimitations	1100000	USD
CY2004Q1	hls	Warrants Issued Potential Number Common Stock Shares WarrantsIssuedPotentialNumberCommonStockShares	2000000	shares
CY2010	hls	Workers Compensation Risks Excess Loss Contracts Salaries And Benefits WorkersCompensationRisksExcessLossContractsSalariesAndBenefits	3200000	USD
CY2009	hls	Workers Compensation Risks Excess Loss Contracts Salaries And Benefits WorkersCompensationRisksExcessLossContractsSalariesAndBenefits	3100000	USD
CY2011	hls	Workers Compensation Risks Excess Loss Contracts Salaries And Benefits WorkersCompensationRisksExcessLossContractsSalariesAndBenefits	2600000	USD
CY2009	hls	Workers Compensation Risks Excess Loss Contracts Total Costs WorkersCompensationRisksExcessLossContractsTotalCosts	3200000	USD
CY2010	hls	Workers Compensation Risks Excess Loss Contracts Total Costs WorkersCompensationRisksExcessLossContractsTotalCosts	3300000	USD
CY2011	hls	Workers Compensation Risks Excess Loss Contracts Total Costs WorkersCompensationRisksExcessLossContractsTotalCosts	2700000	USD
CY2011	dei	Amendment Flag AmendmentFlag	false
CY2011	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2011	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2011	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2011
CY2011	dei	Document Period End Date DocumentPeriodEndDate	2011-12-31
CY2011	dei	Document Type DocumentType	8-K
CY2011	dei	Entity Central Index Key EntityCentralIndexKey	0000785161
CY2012Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	94671611	shares
CY2011	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2011	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2011Q2	dei	Entity Public Float EntityPublicFloat	2500000000	USD
CY2011	dei	Entity Registrant Name EntityRegistrantName	HEALTHSOUTH CORP
CY2011	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2011	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes

Files In Submission

Name	View Source	Status
0000785161-12-000055-index-headers.html	Edgar Link	pending
0000785161-12-000055-index.html	Edgar Link	pending
0000785161-12-000055.txt	Edgar Link	pending
0000785161-12-000055-xbrl.zip	Edgar Link	pending
ex23consent.htm	Edgar Link	pending
ex991item6.htm	Edgar Link	pending
ex992item7.htm	Edgar Link	pending
ex993item8.htm	Edgar Link	pending
ex994item15.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
hls-20120905.xml	Edgar Link	completed
hls-20120905.xsd	Edgar Link	pending
hls-20120905_cal.xml	Edgar Link	unprocessable
hls-20120905_def.xml	Edgar Link	unprocessable
hls-20120905_lab.xml	Edgar Link	unprocessable
hls-20120905_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R109.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R110.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
recasthls10k123112form8-k.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$EHC
Encompass Health Corp Stock $ehc

2011 Q4 Form 8-K Financial Statement

#000078516112000055 Filed on September 06, 2012

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EHC Encompass Health Corp Stock $ehc

2011 Q4 Form 8-K Financial Statement

#000078516112000055 Filed on September 06, 2012

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EHC
Encompass Health Corp Stock $ehc